(lp1
(dp2
S'cdsr_filename'
p3
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p4
sS'pmc_id'
p5
S'PMC2924332'
p6
sS'cdsr_refcode'
p7
VSTD-Humphreys-2010
p8
sS'pm_filename'
p9
V20687955.xml
p10
sS'pdf_filename'
p11
S'1472-6963-10-229.PMC2924332.pdf'
p12
sa(dp13
g3
g4
sg5
S'PMC2943483'
p14
sg7
VSTD-Fatti-2010
p15
sg9
V20877631.xml
p16
sg11
S'pone.0012888.PMC2943483.pdf'
p17
sa(dp18
g3
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p19
sg5
S'PMC1832184'
p20
sg7
VSTD-Lannin-2007
p21
sg9
V17355644.xml
p22
sg11
S'1472-6963-7-42.PMC1832184.pdf'
p23
sa(dp24
g3
g19
sg5
S'PMC3116775'
p25
sg7
VSTD-Spink-2011
p26
sg9
V21680622.xml
p27
sg11
S'bmj.d3411.PMC3116775.pdf'
p28
sa(dp29
g3
g19
sg5
S'PMC2876235'
p30
sg7
VSTD-Haran-2010
p31
sg9
V20501583.xml
p32
sg11
S'bmj.c2265.PMC2876235.pdf'
p33
sa(dp34
g3
g19
sg5
S'PMC2956530'
p35
sg7
VSTD-Conroy-2010
p36
sg9
V20823124.xml
p37
sg11
S'afq096.PMC2956530.pdf'
p38
sa(dp39
g3
g19
sg5
S'PMC3079648'
p40
sg7
VSTD-Dangour-2011
p41
sg9
V21526229.xml
p42
sg11
S'pmed.1001023.PMC3079648.pdf'
p43
sa(dp44
g3
g19
sg5
S'PMC2868162'
p45
sg7
VSTD-Logan-2010
p46
sg9
V20460331.xml
p47
sg11
S'bmj.c2102.PMC2868162.pdf'
p48
sa(dp49
g3
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p50
sg5
S'PMC1891315'
p51
sg7
VSTD-Nilforoushzadeh-2007
p52
sg9
V17466071.xml
p53
sg11
S'1472-6882-7-13.PMC1891315.pdf'
p54
sa(dp55
g3
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p56
sg5
S'PMC539050'
p57
sg7
VSTD-Papasavvas-2004
p58
sg9
V15630469.xml
p59
sg11
S'pmed.0010064.PMC539050.pdf'
p60
sa(dp61
g3
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p62
sg5
S'PMC2364471'
p63
sg7
VSTD-Hager-1996
p64
sg9
V18476075.xml
p65
sg11
S'IDOG-04-097.PMC2364471.pdf'
p66
sa(dp67
g3
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p68
sg5
S'PMC2685130'
p69
sg7
VSTD-Catani-2009
p70
sg9
V19439099.xml
p71
sg11
S'1471-244X-9-22.PMC2685130.pdf'
p72
sa(dp73
g3
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p74
sg5
S'PMC2876235'
p75
sg7
VSTD-Haran-2010
p76
sg9
V20501583.xml
p77
sg11
S'bmj.c2265.PMC2876235.pdf'
p78
sa(dp79
g3
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p80
sg5
S'PMC1352364'
p81
sg7
VSTD-Elliott-2005
p82
sg9
V16371154.xml
p83
sg11
S'1471-2334-5-115.PMC1352364.pdf'
p84
sa(dp85
g3
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p86
sg5
S'PMC2247066'
p87
sg7
VSTD-Selby-1989
p88
sg9
V2539180.xml
p89
sg11
S'brjcancer00125-0114.PMC2247066.pdf'
p90
sa(dp91
g3
g86
sg5
S'PMC1976928'
p92
sg7
VSTD-Anderson-1984
p93
sg9
V6378236.xml
p94
sg11
S'brjcancer00105-0047.PMC1976928.pdf'
p95
sa(dp96
g3
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p97
sg5
S'PMC1784814'
p98
sg7
VSTD-Noyes-1998
p99
sg9
V9894177.xml
p100
sg11
S'9894177.PMC1784814.pdf'
p101
sa(dp102
g3
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p103
sg5
S'PMC1459867'
p104
sg7
VSTD-Finsen-2006
p105
sg9
V16646970.xml
p106
sg11
S'1471-2288-6-19.PMC1459867.pdf'
p107
sa(dp108
g3
g103
sg5
S'PMC1280926'
p109
sg7
VSTD-Cockayne-2005
p110
sg9
V16250910.xml
p111
sg11
S'1471-2288-5-34.PMC1280926.pdf'
p112
sa(dp113
g3
g103
sg5
S'PMC534094'
p114
sg7
VSTD-Roberts-2004
p115
sg9
V15533256.xml
p116
sg11
S'1472-6963-4-30.PMC534094.pdf'
p117
sa(dp118
g3
g103
sg5
S'PMC1190172'
p119
sg7
VSTD-McKenzie_x002d_McHarg-2005
p120
sg9
V16091137.xml
p121
sg11
S'1472-6963-5-52.PMC1190172.pdf'
p122
sa(dp123
g3
g103
sg5
S'PMC1201139'
p124
sg7
VSTD-Kenyon-2005
p125
sg9
V16109160.xml
p126
sg11
S'1472-6963-5-55.PMC1201139.pdf'
p127
sa(dp128
g3
g103
sg5
S'PMC2427026'
p129
sg7
VSTD-Lavelle-2008
p130
sg9
V18507819.xml
p131
sg11
S'1472-6963-8-113.PMC2427026.pdf'
p132
sa(dp133
g3
g103
sg5
S'PMC534787'
p134
sg7
VSTD-Harrison-2004
p135
sg9
V15537429.xml
p136
sg11
S'1472-6963-4-31.PMC534787.pdf'
p137
sa(dp138
g3
g103
sg5
S'PMC449720'
p139
sg7
VSTD-Moses-2004
p140
sg9
V15222889.xml
p141
sg11
S'1472-6963-4-14.PMC449720.pdf'
p142
sa(dp143
g3
g103
sg5
S'PMC64502'
p144
sg7
VSTD-Clark-TJ-2001
p145
sg9
V11782286.xml
p146
sg11
S'1471-2288-1-12.PMC64502.pdf'
p147
sa(dp148
g3
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p149
sg5
S'PMC2409647'
p150
sg7
VSTD-Body-2004
p151
sg9
V15026791.xml
p152
sg11
S'90-6601663a.PMC2409647.pdf'
p153
sa(dp154
g3
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p155
sg5
S'PMC2275406'
p156
sg7
VSTD-Ziboh-2004
p157
sg9
V15154607.xml
p158
sg11
S'CDI-11-013.PMC2275406.pdf'
p159
sa(dp160
g3
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p161
sg5
S'PMC3369588'
p162
sg7
VSTD-Fridkin-2002
p163
sg9
V12095438.xml
p164
sg11
S'01-0465_FinalR.PMC3369588.pdf'
p165
sa(dp166
g3
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p167
sg5
S'PMC1891438'
p168
sg7
VSTD-Luabeya-2007
p169
sg9
V17593956.xml
p170
sg11
S'pone.0000541.PMC1891438.pdf'
p171
sa(dp172
g3
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p173
sg5
S'PMC2871073'
p174
sg7
VSTD-Del-Romero-2010
p175
sg9
V20472675.xml
p176
sg11
S'bmj.c2205.PMC2871073.pdf'
p177
sa(dp178
g3
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p179
sg5
S'PMC1949842'
p180
sg7
VSTD-Tonwe_x002d_Gold-2007
p181
sg9
V17713983.xml
p182
sg11
S'pmed.0040257.PMC1949842.pdf'
p183
sa(dp184
g3
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p185
sg5
S'PMC2363468'
p186
sg7
VSTD-Domenge-2000
p187
sg9
V11189100.xml
p188
sg11
S'83-6691512a.PMC2363468.pdf'
p189
sa(dp190
g3
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p191
sg5
S'PMC2386789'
p192
sg7
VSTD-Lenssen-2008
p193
sg9
V18442423.xml
p194
sg11
S'1471-2474-9-60.PMC2386789.pdf'
p195
sa(dp196
g3
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p197
sg5
S'PMC2565754'
p198
sg7
VSTD-Kerse-2008
p199
sg9
V18845605.xml
p200
sg11
S'bmj.a1445.PMC2565754.pdf'
p201
sa(dp202
g3
g197
sg5
S'PMC415557'
p203
sg7
VSTD-Crotty-2004b
p204
sg9
V15066200.xml
p205
sg11
S'1472-6963-4-6.PMC415557.pdf'
p206
sa(dp207
g3
g197
sg5
S'PMC1766476'
p208
sg7
VSTD-Stenvall-2007
p209
sg9
V17061151.xml
p210
sg11
S'198_2006_Article_226.PMC1766476.pdf'
p211
sa(dp212
g3
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p213
sg5
S'PMC2330032'
p214
sg7
VSTD-EPHT-2006
p215
sg9
V18366766.xml
p216
sg11
S'1472-6874-8-5.PMC2330032.pdf'
p217
sa(dp218
g3
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p219
sg5
S'PMC2376845'
p220
sg7
VSTD-Lauretti-2003
p221
sg9
V14647133.xml
p222
sg11
S'89-6601365a.PMC2376845.pdf'
p223
sa(dp224
g3
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p225
sg5
S'PMC3476141'
p226
sg7
VSTD-Campos-2007
p227
sg9
V17563840.xml
p228
sg11
S'10194_2007_Article_387.PMC3476141.pdf'
p229
sa(dp230
g3
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p231
sg5
S'PMC3281242'
p232
sg7
VSTD-Rennard-2011
p233
sg9
V22080588.xml
p234
sg11
S'ntr220.PMC3281242.pdf'
p235
sa(dp236
g3
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p237
sg5
S'PMC2956152'
p238
sg7
VSTD-Avasthi-2001
p239
sg9
V21407865.xml
p240
sg11
S'IJPsy-43-257.PMC2956152.pdf'
p241
sa(dp242
g3
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p243
sg5
S'PMC2888216'
p244
sg7
VSTD-Becker-2010
p245
sg9
V20370912.xml
p246
sg11
S'ar2978.PMC2888216.pdf'
p247
sa(dp248
g3
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p249
sg5
S'PMC1950500'
p250
sg7
VSTD-Curtis-2007
p251
sg9
V17640375.xml
p252
sg11
S'1471-2431-7-27.PMC1950500.pdf'
p253
sa(dp254
g3
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p255
sg5
S'PMC2936828'
p256
sg7
VSTD-Dobbins-2009
p257
sg9
V19775439.xml
p258
sg11
S'1748-5908-4-61.PMC2936828.pdf'
p259
sa(dp260
g3
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p261
sg5
S'PMC1913175'
p262
sg7
VSTD-Rutten_x002d_van-Molken-2007
p263
sg9
V17370096.xml
p264
sg11
S'10198_2007_Article_39.PMC1913175.pdf'
p265
sa(dp266
g3
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p267
sg5
S'PMC2679061'
p268
sg7
VSTD-Ethgen-2009
p269
sg9
V19358717.xml
p270
sg11
S'1471-2288-9-24.PMC2679061.pdf'
p271
sa(dp272
g3
g267
sg5
S'PMC2886040'
p273
sg7
VSTD-Yu-2010
p274
sg9
V20482769.xml
p275
sg11
S'1745-6215-11-59.PMC2886040.pdf'
p276
sa(dp277
g3
g267
sg5
S'PMC2844941'
p278
sg7
VSTD-Hopewell-2010
p279
sg9
V20332510.xml
p280
sg11
S'bmj.c723.PMC2844941.pdf'
p281
sa(dp282
g3
g267
sg5
S'PMC2788535'
p283
sg7
VSTD-Partsinevelou-2009
p284
sg9
V19930576.xml
p285
sg11
S'1745-6215-10-106.PMC2788535.pdf'
p286
sa(dp287
g3
g267
sg5
S'PMC2216683'
p288
sg7
VSTD-Prady-2008
p289
sg9
V18270568.xml
p290
sg11
S'pone.0001577.PMC2216683.pdf'
p291
sa(dp292
g3
g267
sg5
S'PMC2822812'
p293
sg7
VSTD-Montan_x00e9_-2010
p294
sg9
V20067642.xml
p295
sg11
S'1472-6904-10-2.PMC2822812.pdf'
p296
sa(dp297
g3
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p298
sg5
S'PMC2361948'
p299
sg7
VSTD-Senkus_x002d_Konefka-2005
p300
sg9
V15770205.xml
p301
sg11
S'92-6602477a.PMC2361948.pdf'
p302
sa(dp303
g3
g298
sg5
S'PMC1977779'
p304
sg7
VSTD-MRC-1992
p305
sg9
V1377484.xml
p306
sg11
S'brjcancer00070-0150.PMC1977779.pdf'
p307
sa(dp308
g3
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p309
sg5
S'PMC2890979'
p310
sg7
VSTD-Frankel-2010
p311
sg9
V20058059.xml
p312
sg11
S'10803_2009_Article_932.PMC2890979.pdf'
p313
sa(dp314
g3
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p315
sg5
S'PMC2375236'
p316
sg7
VSTD-Brown-2001
p317
sg9
V11720460.xml
p318
sg11
S'85-6692073a.PMC2375236.pdf'
p319
sa(dp320
g3
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p321
sg5
S'PMC3116927'
p322
sg7
VSTD-Florence-2011
p323
sg9
V21680632.xml
p324
sg11
S'bmj.d3313.PMC3116927.pdf'
p325
sa(dp326
g3
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p327
sg5
S'PMC2777786'
p328
sg7
VSTD-ENGAGE-2009
p329
sg9
V19684043.xml
p330
sg11
S'dep291.PMC2777786.pdf'
p331
sa(dp332
g3
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p333
sg5
S'PMC2658826'
p334
sg7
VSTD-Howden_x002d_Chapman-2008
p335
sg9
V18812366.xml
p336
sg11
S'bmj.a1411.PMC2658826.pdf'
p337
sa(dp338
g3
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p339
sg5
S'PMC2638601'
p340
sg7
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p341
sg9
V18979150.xml
p342
sg11
S'10165_2008_Article_125.PMC2638601.pdf'
p343
sa(dp344
g3
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p345
sg5
S'PMC3023971'
p346
sg7
VSTD-Driver-2011-age-matched
p347
sg9
V21252104.xml
p348
sg11
S'bmj.d198.PMC3023971.pdf'
p349
sa(dp350
g3
g345
sg5
S'PMC3023971'
p351
sg7
VSTD-Driver-2011-age_x002b_-matched
p352
sg9
V21252104.xml
p353
sg11
S'bmj.d198.PMC3023971.pdf'
p354
sa(dp355
g3
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p356
sg5
S'PMC3216418'
p357
sg7
VSTD-Burton-2006
p358
sg9
V16508640.xml
p359
sg11
S'94-6602975a.PMC3216418.pdf'
p360
sa(dp361
g3
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p362
sg5
S'PMC3232099'
p363
sg7
VSTD-Rafati-2011
p364
sg9
V22615652.xml
p365
sg11
S'DARU-19-154.PMC3232099.pdf'
p366
sa(dp367
g3
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p368
sg5
S'PMC3126807'
p369
sg7
VSTD-Rachow-2011
p370
sg9
V21738575.xml
p371
sg11
S'pone.0020458.PMC3126807.pdf'
p372
sa(dp373
g3
g368
sg5
S'PMC3144192'
p374
sg7
VSTD-Scott-2011
p375
sg9
V21814495.xml
p376
sg11
S'pmed.1001061.PMC3144192.pdf'
p377
sa(dp378
g3
g368
sg5
S'PMC3144215'
p379
sg7
VSTD-Lawn-2011
p380
sg9
V21818180.xml
p381
sg11
S'pmed.1001067.PMC3144215.pdf'
p382
sa(dp383
g3
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p384
sg5
S'PMC2957385'
p385
sg7
VSTD-Pakasi-2010
p386
sg9
V20920186.xml
p387
sg11
S'1475-2891-9-41.PMC2957385.pdf'
p388
sa(dp389
g3
g384
sg5
S'PMC2767482'
p390
sg7
VSTD-Martins-2009
p391
sg9
V19858174.xml
p392
sg11
S'bmj.b4248.PMC2767482.pdf'
p393
sa(dp394
g3
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p395
sg5
S'PMC2607225'
p396
sg7
VSTD-Johansson-2008
p397
sg9
V19018255.xml
p398
sg11
S'6604789a.PMC2607225.pdf'
p399
sa(dp400
g3
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p401
sg5
S'PMC2364551'
p402
sg7
VSTD-Eriksen-1997
p403
sg9
V18476153.xml
p404
sg11
S'IDOG-05-286.PMC2364551.pdf'
p405
sa(dp406
g3
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p407
sg5
S'PMC3108665'
p408
sg7
VSTD-Katsourakis-2010
p409
sg9
V21694864.xml
p410
sg11
S'ceg-3-179.PMC3108665.pdf'
p411
sa(dp412
g3
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p413
sg5
S'PMC2432028'
p414
sg7
VSTD-Cornuz-2008
p415
sg9
V18575629.xml
p416
sg11
S'pone.0002547.PMC2432028.pdf'
p417
sa(dp418
g3
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p419
sg5
S'PMC3015793'
p420
sg7
VSTD-Ricca-2007
p421
sg9
V17663093.xml
p422
sg11
S'jsls-11-1-54.PMC3015793.pdf'
p423
sa(dp424
g3
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p425
sg5
S'PMC3055095'
p426
sg7
VSTD-Ataoglu-2003
p427
sg9
V12923337.xml
p428
sg11
S'12923337.PMC3055095.pdf'
p429
sa(dp430
g3
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p431
sg5
S'PMC2627861'
p432
sg7
VSTD-Ettinger-2009
p433
sg9
V19165383.xml
p434
sg11
S'EHP-117-26.PMC2627861.pdf'
p435
sa(dp436
g3
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p437
sg5
S'PMC2943441'
p438
sg7
VSTD-Yeboah_x002d_Antwi-2010
p439
sg9
V20877714.xml
p440
sg11
S'pmed.1000340.PMC2943441.pdf'
p441
sa(dp442
g3
g437
sg5
S'PMC2287184'
p443
sg7
VSTD-Kouyate-2008
p444
sg9
V18364043.xml
p445
sg11
S'1475-2875-7-50.PMC2287184.pdf'
p446
sa(dp447
g3
g437
sg5
S'PMC3130036'
p448
sg7
VSTD-Mubi-2011
p449
sg9
V21750697.xml
p450
sg11
S'pone.0019753.PMC3130036.pdf'
p451
sa(dp452
g3
g437
sg5
S'PMC3104978'
p453
sg7
VSTD-Kangwana-2011
p454
sg9
V21655317.xml
p455
sg11
S'pmed.1000437.PMC3104978.pdf'
p456
sa(dp457
g3
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p458
sg5
S'PMC2695684'
p459
sg7
VSTD-Akhter-2009
p460
sg9
V19417743.xml
p461
sg11
S'6605088a.PMC2695684.pdf'
p462
sa(dp463
g3
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p464
sg5
S'PMC3172444'
p465
sg7
VSTD-Channabasavanna-1987
p466
sg9
V21927264.xml
p467
sg11
S'IJPsy-29-333.PMC3172444.pdf'
p468
sa(dp469
g3
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p470
sg5
S'PMC2965151'
p471
sg7
VSTD-Smith-2010
p472
sg9
V20978060.xml
p473
sg11
S'bmj.c5370.PMC2965151.pdf'
p474
sa(dp475
g3
g470
sg5
S'PMC3106362'
p476
sg7
VSTD-Steckelberg-2011
p477
sg9
V21636633.xml
p478
sg11
S'bmj.d3193.PMC3106362.pdf'
p479
sa(dp480
g3
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p481
sg5
S'PMC3100912'
p482
sg7
VSTD-Vadillo_x002d_Ortega-2011
p483
sg9
V21596735.xml
p484
sg11
S'bmj.d2901.PMC3100912.pdf'
p485
sa(dp486
g3
g481
sg5
S'PMC2577799'
p487
sg7
VSTD-Zeng-2008
p488
sg9
V18996930.xml
p489
sg11
S'bmj.a2001.PMC2577799.pdf'
p490
sa(dp491
g3
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p492
sg5
S'PMC2376929'
p493
sg7
VSTD-Fry-2003
p494
sg9
V12915873.xml
p495
sg11
S'89-6601170a.PMC2376929.pdf'
p496
sa(dp497
g3
g492
sg5
S'PMC2360713'
p498
sg7
VSTD-Young-2006
p499
sg9
V17047645.xml
p500
sg11
S'95-6603389a.PMC2360713.pdf'
p501
sa(dp502
g3
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p503
sg5
S'PMC2922723'
p504
sg7
VSTD-Osman-2008
p505
sg9
V19703826.xml
p506
sg11
S'thorax111492.PMC2922723.pdf'
p507
sa(dp508
g3
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p509
sg5
S'PMC3055095'
p510
sg7
VSTD-Ataoglu-2003
p511
sg9
V12923337.xml
p512
sg11
S'12923337.PMC3055095.pdf'
p513
sa(dp514
g3
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p515
sg5
S'PMC1687208'
p516
sg7
VSTD-Priotto-2006
p517
sg9
V17160135.xml
p518
sg11
S'pctr.0010039.PMC1687208.pdf'
p519
sa(dp520
g3
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p521
sg5
S'PMC2835853'
p522
sg7
VSTD-Benn-2010
p523
sg9
V20215360.xml
p524
sg11
S'bmj.c1101.PMC2835853.pdf'
p525
sa(dp526
g3
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p527
sg5
S'PMC2635594'
p528
sg7
VSTD-Hoddinott-2009
p529
sg9
V19181729.xml
p530
sg11
S'bmj.a3026.PMC2635594.pdf'
p531
sa(dp532
g3
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p533
sg5
S'PMC1483908'
p534
sg7
VSTD-Corbett-2006
p535
sg9
V16796402.xml
p536
sg11
S'pmed.0030238.PMC1483908.pdf'
p537
sa(dp538
g3
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p539
sg5
S'PMC3109380'
p540
sg7
VSTD-Coskun-2011
p541
sg9
V21789385.xml
p542
sg11
S'cln-66-05-811.PMC3109380.pdf'
p543
sa(dp544
g3
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p545
sg5
S'PMC2639595'
p546
sg7
VSTD-Beran-2009a
p547
sg9
V19149900.xml
p548
sg11
S'1471-2334-9-2.PMC2639595.pdf'
p549
sa(dp550
g3
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p551
sg5
S'PMC3236524'
p552
sg7
VSTD-Varkey-2011
p553
sg9
V21890526.xml
p554
sg11
S'10.1177_0333102411419681.PMC3236524.pdf'
p555
sa(dp556
g3
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p557
sg5
S'PMC2691927'
p558
sg7
VSTD-Bertleff-2009
p559
sg9
V19430829.xml
p560
sg11
S'268_2009_Article_54.PMC2691927.pdf'
p561
sa(dp562
g3
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p563
sg5
S'PMC2666722'
p564
sg7
VSTD-Chen-2009
p565
sg9
V19284644.xml
p566
sg11
S'1471-2458-9-81.PMC2666722.pdf'
p567
sa(dp568
g3
g563
sg5
S'PMC2364646'
p569
sg7
VSTD-Cowling-2008
p570
sg9
V18461182.xml
p571
sg11
S'pone.0002101.PMC2364646.pdf'
p572
sa(dp573
g3
g563
sg5
S'PMC3322931'
p574
sg7
VSTD-Wu-2004
p575
sg9
V15030685.xml
p576
sg11
S'03-0730.PMC3322931.pdf'
p577
sa(dp578
g3
g563
sg5
S'PMC2662657'
p579
sg7
VSTD-MacIntyre-2009
p580
sg9
V19193267.xml
p581
sg11
S'08-1167_finalRCME.PMC2662657.pdf'
p582
sa(dp583
g3
g563
sg5
S'PMC3323085'
p584
sg7
VSTD-Lau-2004a
p585
sg9
V15200846.xml
p586
sg11
S'03-0628.PMC3323085.pdf'
p587
sa(dp588
g3
g563
sg5
S'PMC3152767'
p589
sg7
VSTD-Cowling-2010
p590
sg9
V20353566.xml
p591
sg11
S'1471-2334-10-82.PMC3152767.pdf'
p592
sa(dp593
g3
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p594
sg5
S'PMC3278944'
p595
sg7
VSTD-Psaradellis-2010
p596
sg9
V22371721.xml
p597
sg11
S'AMS-6-14277.PMC3278944.pdf'
p598
sa(dp599
g3
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p600
sg5
S'PMC2375173'
p601
sg7
VSTD-Atzpodien-2002
p602
sg9
V11870502.xml
p603
sg11
S'86-6600043a.PMC2375173.pdf'
p604
sa(dp605
g3
g600
sg5
S'PMC2150174'
p606
sg7
VSTD-Johnston-1998
p607
sg9
V9579834.xml
p608
sg11
S'brjcancer00084-0086.PMC2150174.pdf'
p609
sa(dp610
g3
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p611
sg5
S'PMC2063048'
p612
sg7
VSTD-Shepherd-1998
p613
sg9
V9744511.xml
p614
sg11
S'brjcancer00005-0127.PMC2063048.pdf'
p615
sa(dp616
g3
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p617
sg5
S'PMC2758893'
p618
sg7
VSTD-Gentile-2009
p619
sg9
V19765270.xml
p620
sg11
S'1741-7015-7-49.PMC2758893.pdf'
p621
sa(dp622
g3
g617
sg5
S'PMC2040215'
p623
sg7
VSTD-Lazaar-2007
p624
sg9
V17718785.xml
p625
sg11
S'apa0096-1315.PMC2040215.pdf'
p626
sa(dp627
g3
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p628
sg5
S'PMC1964758'
p629
sg7
VSTD-Rosenberg-2007
p630
sg9
V17683577.xml
p631
sg11
S'1471-2474-8-76.PMC1964758.pdf'
p632
sa(dp633
g3
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p634
sg5
S'PMC415557'
p635
sg7
VSTD-Crotty-2004
p636
sg9
V15066200.xml
p637
sg11
S'1472-6963-4-6.PMC415557.pdf'
p638
sa(dp639
g3
g634
sg5
S'PMC1472698'
p640
sg7
VSTD-Fretheim-2006
p641
sg9
V16737349.xml
p642
sg11
S'pmed.0030216.PMC1472698.pdf'
p643
sa(dp644
g3
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p645
sg5
S'PMC394324'
p646
sg7
VSTD-Schultz-2004
p647
sg9
V15113451.xml
p648
sg11
S'1471-230X-4-5.PMC394324.pdf'
p649
sa(dp650
g3
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p651
sg5
S'PMC2890340'
p652
sg7
VSTD-Callaway-2010
p653
sg9
V20357374.xml
p654
sg11
S'zdc1457.PMC2890340.pdf'
p655
sa(dp656
g3
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p657
sg5
S'PMC2890340'
p658
sg7
VSTD-Callaway-2010
p659
sg9
V20357374.xml
p660
sg11
S'zdc1457.PMC2890340.pdf'
p661
sa(dp662
g3
g657
sg5
S'PMC3078095'
p663
sg7
VSTD-Korpi_x002d_Hyovalti-2011
p664
sg9
V21429234.xml
p665
sg11
S'1471-2458-11-179.PMC3078095.pdf'
p666
sa(dp667
g3
g657
sg5
S'PMC2681032'
p668
sg7
VSTD-Moses-2009
p669
sg9
V19279301.xml
p670
sg11
S'zdc996.PMC2681032.pdf'
p671
sa(dp672
g3
g657
sg5
S'PMC3096610'
p673
sg7
VSTD-Luoto-2011
p674
sg9
V21610860.xml
p675
sg11
S'pmed.1001036.PMC3096610.pdf'
p676
sa(dp677
g3
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p678
sg5
S'PMC3015252'
p679
sg7
VSTD-Ott-1998
p680
sg9
V10036122.xml
p681
sg11
S'jsls-2-4-321.PMC3015252.pdf'
p682
sa(dp683
g3
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p684
sg5
S'PMC1784606'
p685
sg7
VSTD-Scott-2002
p686
sg9
V12530483.xml
p687
sg11
S'12530483.PMC1784606.pdf'
p688
sa(dp689
g3
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p690
sg5
S'PMC2376376'
p691
sg7
VSTD-Boogaerts-2003
p692
sg9
V12671693.xml
p693
sg11
S'88-6600801a.PMC2376376.pdf'
p694
sa(dp695
g3
g690
sg5
S'PMC2361228'
p696
sg7
VSTD-Wilkinson-2006
p697
sg9
V16570051.xml
p698
sg11
S'94-6603004a.PMC2361228.pdf'
p699
sa(dp700
g3
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p701
sg5
S'PMC2835853'
p702
sg7
VSTD-Benn-2010
p703
sg9
V20215360.xml
p704
sg11
S'bmj.c1101.PMC2835853.pdf'
p705
sa(dp706
g3
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p707
sg5
S'PMC524376'
p708
sg7
VSTD-Moorthy-2004b
p709
sg9
V15526058.xml
p710
sg11
S'pmed.0010033.PMC524376.pdf'
p711
sa(dp712
g3
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p713
sg5
S'PMC2575601'
p714
sg7
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p715
sg9
V18759980.xml
p716
sg11
S'cc6999.PMC2575601.pdf'
p717
sa(dp718
g3
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p719
sg5
S'PMC2650992'
p720
sg7
VSTD-Ko-2009
p721
sg9
V19270819.xml
p722
sg11
S'jkms-24-92.PMC2650992.pdf'
p723
sa(dp724
g3
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p725
sg5
S'PMC2253708'
p726
sg7
VSTD-Meyer-2008
p727
sg9
V17995993.xml
p728
sg11
S'add0103-0294.PMC2253708.pdf'
p729
sa(dp730
g3
g725
sg5
S'PMC2268921'
p731
sg7
VSTD-Young-2008
p732
sg9
V18304363.xml
p733
sg11
S'1471-2296-9-16.PMC2268921.pdf'
p734
sa(dp735
g3
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p736
sg5
S'PMC2291568'
p737
sg7
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p738
sg9
V18414647.xml
p739
sg11
S'pntd.0000223.PMC2291568.pdf'
p740
sa(dp741
g3
g736
sg5
S'PMC3161357'
p742
sg7
VSTD-Kirwan-2010
p743
sg9
V20858280.xml
p744
sg11
S'1471-2334-10-277.PMC3161357.pdf'
p745
sa(dp746
g3
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p747
sg5
S'PMC2424122'
p748
sg7
VSTD-_x005e_Horst-2005
p749
sg9
V18568115.xml
p750
sg11
S'ndt-0104-349.PMC2424122.pdf'
p751
sa(dp752
g3
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p753
sg5
S'PMC2845038'
p754
sg7
VSTD-Ziegler-2010
p755
sg9
V20067958.xml
p756
sg11
S'zdc839.PMC2845038.pdf'
p757
sa(dp758
g3
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p759
sg5
S'PMC1810361'
p760
sg7
VSTD-Qu-2007
p761
sg9
V17342250.xml
p762
sg11
S'nel053.PMC1810361.pdf'
p763
sa(dp764
g3
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p765
sg5
S'PMC3217057'
p766
sg7
VSTD-Bouzari-2011
p767
sg9
V22026956.xml
p768
sg11
S'1756-0500-4-444.PMC3217057.pdf'
p769
sa(dp770
g3
g765
sg5
S'PMC3233526'
p771
sg7
VSTD-Yekta-2011
p772
sg9
V22162919.xml
p773
sg11
S'tcrm-7-421.PMC3233526.pdf'
p774
sa(dp775
g3
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p776
sg5
S'PMC1892551'
p777
sg7
VSTD-Starobin-2007
p778
sg9
V17547746.xml
p779
sg11
S'1749-8090-2-25.PMC1892551.pdf'
p780
sa(dp781
g3
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p782
sg5
S'PMC2780654'
p783
sg7
VSTD-Tan-2008
p784
sg9
V18545884.xml
p785
sg11
S'10151_2008_Article_405.PMC2780654.pdf'
p786
sa(dp787
g3
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p788
sg5
S'PMC2708138'
p789
sg7
VSTD-Wamalwa-2009
p790
sg9
V19549342.xml
p791
sg11
S'1758-2652-12-8.PMC2708138.pdf'
p792
sa(dp793
g3
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p794
sg5
S'PMC2684117'
p795
sg7
VSTD-Patel-2009
p796
sg9
V19416499.xml
p797
sg11
S'1741-7015-7-22.PMC2684117.pdf'
p798
sa(dp799
g3
g794
sg5
S'PMC2684117'
p800
sg7
VSTD-Patel-2009a-_x0028_zinc_x0029_
p801
sg9
V19416499.xml
p802
sg11
S'1741-7015-7-22.PMC2684117.pdf'
p803
sa(dp804
g3
g794
sg5
S'PMC2684117'
p805
sg7
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p806
sg9
V19416499.xml
p807
sg11
S'1741-7015-7-22.PMC2684117.pdf'
p808
sa(dp809
g3
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p810
sg5
S'PMC1977737'
p811
sg7
VSTD-d-SGCTG-1986
p812
sg9
V1739629.xml
p813
sg11
S'brjcancer00066-0137.PMC1977737.pdf'
p814
sa(dp815
g3
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p816
sg5
S'PMC2253708'
p817
sg7
VSTD-Meyer-2008
p818
sg9
V17995993.xml
p819
sg11
S'add0103-0294.PMC2253708.pdf'
p820
sa(dp821
g3
g816
sg5
S'PMC1829425'
p822
sg7
VSTD-Unrod-2007
p823
sg9
V17372796.xml
p824
sg11
S'11606_2006_Article_69.PMC1829425.pdf'
p825
sa(dp826
g3
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p827
sg5
S'PMC2950952'
p828
sg7
VSTD-Lalit-2004
p829
sg9
V21206792.xml
p830
sg11
S'IJPsy-46-333.PMC2950952.pdf'
p831
sa(dp832
g3
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p833
sg5
S'PMC2363351'
p834
sg7
VSTD-Windbichler-2000
p835
sg9
V10735496.xml
p836
sg11
S'82-6691053a.PMC2363351.pdf'
p837
sa(dp838
g3
g833
sg5
S'PMC2364769'
p839
sg7
VSTD-Hall-2004
p840
sg9
V15305182.xml
p841
sg11
S'91-6602037a.PMC2364769.pdf'
p842
sa(dp843
g3
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p844
sg5
S'PMC2048661'
p845
sg7
VSTD-Kalilani-2007
p846
sg9
V18000538.xml
p847
sg11
S'pone.0001166.PMC2048661.pdf'
p848
sa(dp849
g3
g844
sg5
S'PMC1533839'
p850
sg7
VSTD-Coulibaly-2006
p851
sg9
V16776817.xml
p852
sg11
S'1475-2875-5-49.PMC1533839.pdf'
p853
sa(dp854
g3
VCD000448 v. 10.0 St John's wort for major depression.rm5
p855
sg5
S'PMC1538611'
p856
sg7
VSTD-Kasper-2006
p857
sg9
V16796730.xml
p858
sg11
S'1741-7015-4-14.PMC1538611.pdf'
p859
sa(dp860
g3
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p861
sg5
S'PMC1832131'
p862
sg7
VSTD-Horn-2007
p863
sg9
V17173716.xml
p864
sg11
S'PCD41A08.PMC1832131.pdf'
p865
sa(dp866
g3
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p867
sg5
S'PMC2817867'
p868
sg7
VSTD-McKay-2009
p869
sg9
V20148084.xml
p870
sg11
S'HPB2009-346863.PMC2817867.pdf'
p871
sa(dp872
g3
g867
sg5
S'PMC3204557'
p873
sg7
VSTD-Kim-2011
p874
sg9
V22066097.xml
p875
sg11
S'jkss-81-25.PMC3204557.pdf'
p876
sa(dp877
g3
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p878
sg5
S'PMC2946956'
p879
sg7
VSTD-Gajdos-2010
p880
sg9
V20927359.xml
p881
sg11
S'pmed.1000345.PMC2946956.pdf'
p882
sa(dp883
g3
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p884
sg5
S'PMC2577799'
p885
sg7
VSTD-Zeng-2008-_x0028_C_x0029_
p886
sg9
V18996930.xml
p887
sg11
S'bmj.a2001.PMC2577799.pdf'
p888
sa(dp889
g3
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p890
sg5
S'PMC2890332'
p891
sg7
VSTD-Faglia-2010
p892
sg9
V20357377.xml
p893
sg11
S'zdc1419.PMC2890332.pdf'
p894
sa(dp895
g3
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p896
sg5
S'PMC2074683'
p897
sg7
VSTD-MRC-LU11
p898
sg9
V8761382.xml
p899
sg11
S'brjcancer00020-0142.PMC2074683.pdf'
p900
sa(dp901
g3
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p902
sg5
S'PMC2364007'
p903
sg7
VSTD-Faithfull-2001
p904
sg9
V11747326.xml
p905
sg11
S'85-6692173a.PMC2364007.pdf'
p906
sa(dp907
g3
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p908
sg5
S'PMC1913177'
p909
sg7
VSTD-de-Vries-2007a
p910
sg9
V17372669.xml
p911
sg11
S'268_2006_Article_502.PMC1913177.pdf'
p912
sa(dp913
g3
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p914
sg5
S'PMC2409178'
p915
sg7
VSTD-Horita-2007
p916
sg9
V17497466.xml
p917
sg11
S'lrnf29-441.PMC2409178.pdf'
p918
sa(dp919
g3
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p920
sg5
S'PMC3302710'
p921
sg7
VSTD-Soltanian-2010
p922
sg9
V22427772.xml
p923
sg11
S'AMS-6-6-950.PMC3302710.pdf'
p924
sa(dp925
g3
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p926
sg5
S'PMC2664121'
p927
sg7
VSTD-Castro-2008
p928
sg9
V18719756.xml
p929
sg11
S'cln63_4p0465.PMC2664121.pdf'
p930
sa(dp931
g3
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p932
sg5
S'PMC2361644'
p933
sg7
VSTD-Michaud-2005
p934
sg9
V16175184.xml
p935
sg11
S'93-6602788a.PMC2361644.pdf'
p936
sa(dp937
g3
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p938
sg5
S'PMC3216983'
p939
sg7
VSTD-ba-Kissling-2011
p940
sg9
V22110695.xml
p941
sg11
S'pone.0027622.PMC3216983.pdf'
p942
sa(dp943
g3
g938
sg5
S'PMC3019108'
p944
sg7
VSTD-ba-Valenciano-2011
p945
sg9
V21379316.xml
p946
sg11
S'pmed.1000388.PMC3019108.pdf'
p947
sa(dp948
g3
g938
sg5
S'PMC2966412'
p949
sg7
VSTD-ab-Mallory-2010
p950
sg9
V21060780.xml
p951
sg11
S'pone.0013755.PMC2966412.pdf'
p952
sa(dp953
g3
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p954
sg5
S'PMC2721929'
p955
sg7
VSTD-Song-2006
p956
sg9
V17179687.xml
p957
sg11
S'jkms-21-1060.PMC2721929.pdf'
p958
sa(dp959
g3
g954
sg5
S'PMC2325270'
p960
sg7
VSTD-Chancellor-2008
p961
sg9
V18324952.xml
p962
sg11
S'ijcp0062-0606.PMC2325270.pdf'
p963
sa(dp964
g3
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p965
sg5
S'PMC1368976'
p966
sg7
VSTD-Bautmans-2005
p967
sg9
V16372905.xml
p968
sg11
S'1471-2318-5-17.PMC1368976.pdf'
p969
sa(dp970
g3
g965
sg5
S'PMC2565754'
p971
sg7
VSTD-Kerse-2008
p972
sg9
V18845605.xml
p973
sg11
S'bmj.a1445.PMC2565754.pdf'
p974
sa(dp975
g3
g965
sg5
S'PMC2736373'
p976
sg7
VSTD-Sackley-2009
p977
sg9
V19723707.xml
p978
sg11
S'bmj.b3123.PMC2736373.pdf'
p979
sa(dp980
g3
g965
sg5
S'PMC471553'
p981
sg7
VSTD-Chin-A-Paw-2004
p982
sg9
V15233841.xml
p983
sg11
S'1471-2318-4-5.PMC471553.pdf'
p984
sa(dp985
g3
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p986
sg5
S'PMC2074540'
p987
sg7
VSTD-Gebbia-1996
p988
sg9
V8664133.xml
p989
sg11
S'brjcancer00040-0126.PMC2074540.pdf'
p990
sa(dp991
g3
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p992
sg5
S'PMC1891315'
p993
sg7
VSTD-Nilforoushzadeh-2007
p994
sg9
V17466071.xml
p995
sg11
S'1472-6882-7-13.PMC1891315.pdf'
p996
sa(dp997
g3
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p998
sg5
S'PMC1977284'
p999
sg7
VSTD-a01-MRC-LU02
p1000
sg9
V3907687.xml
p1001
sg11
S'brjcancer00098-0053.PMC1977284.pdf'
p1002
sa(dp1003
g3
g998
sg5
S'PMC1971367'
p1004
sg7
VSTD-d04-RLW-8351
p1005
sg9
V1691921.xml
p1006
sg11
S'brjcancer00224-0118.PMC1971367.pdf'
p1007
sa(dp1008
g3
g998
sg5
S'PMC1971367'
p1009
sg7
VSTD-d06-Southampton
p1010
sg9
V1691921.xml
p1011
sg11
S'brjcancer00224-0118.PMC1971367.pdf'
p1012
sa(dp1013
g3
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p1014
sg5
S'PMC3063826'
p1015
sg7
VSTD-Rosenfeldt-2011
p1016
sg9
V21385466.xml
p1017
sg11
S'1472-6882-11-20.PMC3063826.pdf'
p1018
sa(dp1019
g3
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p1020
sg5
S'PMC2228066'
p1021
sg7
VSTD-Kylmala-1997
p1022
sg9
V9328156.xml
p1023
sg11
S'brjcancer00171-0117.PMC2228066.pdf'
p1024
sa(dp1025
g3
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p1026
sg5
S'PMC2228375'
p1027
sg7
VSTD-Morice-2007
p1028
sg9
V17887990.xml
p1029
sg11
S'ijcp0061-1874.PMC2228375.pdf'
p1030
sa(dp1031
g3
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p1032
sg5
S'PMC1824772'
p1033
sg7
VSTD-Solomon-2007a
p1034
sg9
V17356969.xml
p1035
sg11
S'11606_2006_Article_99.PMC1824772.pdf'
p1036
sa(dp1037
g3
g1032
sg5
S'PMC1824751'
p1038
sg7
VSTD-Lafata-2007
p1039
sg9
V17356966.xml
p1040
sg11
S'11606_2006_Article_60.PMC1824751.pdf'
p1041
sa(dp1042
g3
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p1043
sg5
S'PMC2174463'
p1044
sg7
VSTD-Pavord-2007
p1045
sg9
V17897478.xml
p1046
sg11
S'1465-9921-8-67.PMC2174463.pdf'
p1047
sa(dp1048
g3
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p1049
sg5
S'PMC115863'
p1050
sg7
VSTD-Timmer-2002
p1051
sg9
V11978183.xml
p1052
sg11
S'1471-2288-2-7.PMC115863.pdf'
p1053
sa(dp1054
g3
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p1055
sg5
S'PMC2277446'
p1056
sg7
VSTD-Chel-2008
p1057
sg9
V17874029.xml
p1058
sg11
S'198_2007_Article_465.PMC2277446.pdf'
p1059
sa(dp1060
g3
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p1061
sg5
S'PMC2972638'
p1062
sg7
VSTD-Ito-2010
p1063
sg9
V20049950.xml
p1064
sg11
S'ibd0016-1567.PMC2972638.pdf'
p1065
sa(dp1066
g3
g1061
sg5
S'PMC3269751'
p1067
sg7
VSTD-Kruis-2009
p1068
sg9
V18832520.xml
p1069
sg11
S'GUT-58-02-0233.PMC3269751.pdf'
p1070
sa(dp1071
g3
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p1072
sg5
S'PMC2726958'
p1073
sg7
VSTD-Cao-2009
p1074
sg9
V19508995.xml
p1075
sg11
S'ehp220.PMC2726958.pdf'
p1076
sa(dp1077
g3
VCD000330 v. 12.0 Enemas during labour.rm5
p1078
sg5
S'PMC1468428'
p1079
sg7
VSTD-Cuervo-2006
p1080
sg9
V16545140.xml
p1081
sg11
S'1471-2393-6-8.PMC1468428.pdf'
p1082
sa(dp1083
g3
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p1084
sg5
S'PMC2536666'
p1085
sg7
VSTD-Bahwere-2008
p1086
sg9
V18671876.xml
p1087
sg11
S'1471-2334-8-106.PMC2536666.pdf'
p1088
sa(dp1089
g3
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p1090
sg5
S'PMC2362603'
p1091
sg7
VSTD-Kotwal-1998
p1092
sg9
V18493472.xml
p1093
sg11
S'DTE-04-191.PMC2362603.pdf'
p1094
sa(dp1095
g3
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p1096
sg5
S'PMC2671765'
p1097
sg7
VSTD-Choung-2008
p1098
sg9
V19434268.xml
p1099
sg11
S'ceo-1-201.PMC2671765.pdf'
p1100
sa(dp1101
g3
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p1102
sg5
S'PMC2688140'
p1103
sg7
VSTD-Huh-2009
p1104
sg9
V19239703.xml
p1105
sg11
S'cc7725.PMC2688140.pdf'
p1106
sa(dp1107
g3
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p1108
sg5
S'PMC1269459'
p1109
sg7
VSTD-Bollen-2005
p1110
sg9
V16137357.xml
p1111
sg11
S'cc3737.PMC1269459.pdf'
p1112
sa(dp1113
g3
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p1114
sg5
S'PMC154111'
p1115
sg7
VSTD-Dyhr-2003
p1116
sg9
V12617741.xml
p1117
sg11
S'cc1844.PMC154111.pdf'
p1118
sa(dp1119
g3
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p1120
sg5
S'PMC3081214'
p1121
sg7
VSTD-Makvandi-2011
p1122
sg9
V21495198.xml
p1123
sg11
S'CroatMedJ_52_0159.PMC3081214.pdf'
p1124
sa(dp1125
g3
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p1126
sg5
S'PMC1974786'
p1127
sg7
VSTD-Vichinsky-2007
p1128
sg9
V17233848.xml
p1129
sg11
S'bjh0136-0501.PMC1974786.pdf'
p1130
sa(dp1131
g3
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p1132
sg5
S'PMC3241560'
p1133
sg7
VSTD-Fujisaka-2011
p1134
sg9
V21959870.xml
p1135
sg11
S'bjc2011395a.PMC3241560.pdf'
p1136
sa(dp1137
g3
g1132
sg5
S'PMC2362337'
p1138
sg7
VSTD-Thatcher-1999b
p1139
sg9
V10408844.xml
p1140
sg11
S'80-6690369a.PMC2362337.pdf'
p1141
sa(dp1142
g3
g1132
sg5
S'PMC2362337'
p1143
sg7
VSTD-Thatcher-1999a
p1144
sg9
V10408844.xml
p1145
sg11
S'80-6690369a.PMC2362337.pdf'
p1146
sa(dp1147
g3
g1132
sg5
S'PMC2376376'
p1148
sg7
VSTD-Boogaerts-2003
p1149
sg9
V12671693.xml
p1150
sg11
S'88-6600801a.PMC2376376.pdf'
p1151
sa(dp1152
g3
g1132
sg5
S'PMC2741110'
p1153
sg7
VSTD-Smith-2003b
p1154
sg9
V12799626.xml
p1155
sg11
S'88-6600994a.PMC2741110.pdf'
p1156
sa(dp1157
g3
g1132
sg5
S'PMC2741110'
p1158
sg7
VSTD-Smith-2003c
p1159
sg9
V12799626.xml
p1160
sg11
S'88-6600994a.PMC2741110.pdf'
p1161
sa(dp1162
g3
g1132
sg5
S'PMC2741110'
p1163
sg7
VSTD-Smith-2003a
p1164
sg9
V12799626.xml
p1165
sg11
S'88-6600994a.PMC2741110.pdf'
p1166
sa(dp1167
g3
g1132
sg5
S'PMC2361228'
p1168
sg7
VSTD-Wilkinson-2006
p1169
sg9
V16570051.xml
p1170
sg11
S'94-6603004a.PMC2361228.pdf'
p1171
sa(dp1172
g3
g1132
sg5
S'PMC3228044'
p1173
sg7
VSTD-Pronzato-2010
p1174
sg9
V20798194.xml
p1175
sg11
S'onc935.PMC3228044.pdf'
p1176
sa(dp1177
g3
g1132
sg5
S'PMC2150364'
p1178
sg7
VSTD-Sweeney-1998
p1179
sg9
V9667681.xml
p1180
sg11
S'brjcancer00087-0288.PMC2150364.pdf'
p1181
sa(dp1182
g3
g1132
sg5
S'PMC2362337'
p1183
sg7
VSTD-Thatcher-1999
p1184
sg9
V10408844.xml
p1185
sg11
S'80-6690369a.PMC2362337.pdf'
p1186
sa(dp1187
g3
g1132
sg5
S'PMC2741110'
p1188
sg7
VSTD-Smith-2003
p1189
sg9
V12799626.xml
p1190
sg11
S'88-6600994a.PMC2741110.pdf'
p1191
sa(dp1192
g3
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p1193
sg5
S'PMC1087493'
p1194
sg7
VSTD-Galloway-2005
p1195
sg9
V15804355.xml
p1196
sg11
S'1471-244X-5-18.PMC1087493.pdf'
p1197
sa(dp1198
g3
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p1199
sg5
S'PMC2674549'
p1200
sg7
VSTD-Keystone-2009
p1201
sg9
V19066176.xml
p1202
sg11
S'ard-68-06-0789.PMC2674549.pdf'
p1203
sa(dp1204
g3
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p1205
sg5
S'PMC2722000'
p1206
sg7
VSTD-Jun-2006
p1207
sg9
V17043424.xml
p1208
sg11
S'jkms-21-883.PMC2722000.pdf'
p1209
sa(dp1210
g3
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p1211
sg5
S'PMC2680829'
p1212
sg7
VSTD-Mendoza-2009
p1213
sg9
V19413910.xml
p1214
sg11
S'1471-2458-9-122.PMC2680829.pdf'
p1215
sa(dp1216
g3
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p1217
sg5
S'PMC2206488'
p1218
sg7
VSTD-Gombocz-2007
p1219
sg9
V17697359.xml
p1220
sg11
S'cc6095.PMC2206488.pdf'
p1221
sa(dp1222
g3
g1217
sg5
S'PMC1569382'
p1223
sg7
VSTD-Akech-2006
p1224
sg9
V16998584.xml
p1225
sg11
S'pctr.0010021.PMC1569382.pdf'
p1226
sa(dp1227
g3
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p1228
sg5
S'PMC3076562'
p1229
sg7
VSTD-Bent-2011
p1230
sg9
V20683766.xml
p1231
sg11
S'10803_2010_Article_1078.PMC3076562.pdf'
p1232
sa(dp1233
g3
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p1234
sg5
S'PMC3100911'
p1235
sg7
VSTD-Hellum-2011
p1236
sg9
V21596740.xml
p1237
sg11
S'bmj.d2786.PMC3100911.pdf'
p1238
sa(dp1239
g3
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p1240
sg5
S'PMC2972641'
p1241
sg7
VSTD-Ito-2010
p1242
sg9
V20049949.xml
p1243
sg11
S'ibd0016-1575.PMC2972641.pdf'
p1244
sa(dp1245
g3
g1240
sg5
S'PMC2770408'
p1246
sg7
VSTD-Kane-2008a
p1247
sg9
V19920971.xml
p1248
sg11
S'ppa-2-253.PMC2770408.pdf'
p1249
sa(dp1250
g3
g1240
sg5
S'PMC2564831'
p1251
sg7
VSTD-Kamm-2008
p1252
sg9
V18272546.xml
p1253
sg11
S'GUT-57-07-0893.PMC2564831.pdf'
p1254
sa(dp1255
g3
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p1256
sg5
S'PMC2922697'
p1257
sg7
VSTD-Kasari-2010
p1258
sg9
V20145986.xml
p1259
sg11
S'10803_2010_Article_955.PMC2922697.pdf'
p1260
sa(dp1261
g3
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p1262
sg5
S'PMC3024263'
p1263
sg7
VSTD-Sesay-2011
p1264
sg9
V21214940.xml
p1265
sg11
S'1475-2875-10-2.PMC3024263.pdf'
p1266
sa(dp1267
g3
g1262
sg5
S'PMC3032552'
p1268
sg7
VSTD-Konate-2011
p1269
sg9
V21304925.xml
p1270
sg11
S'pmed.1000408.PMC3032552.pdf'
p1271
sa(dp1272
g3
g1262
sg5
S'PMC2602973'
p1273
sg7
VSTD-Kweku-2008
p1274
sg9
V19098989.xml
p1275
sg11
S'pone.0004000.PMC2602973.pdf'
p1276
sa(dp1277
g3
g1262
sg5
S'PMC3032550'
p1278
sg7
VSTD-Dicko-2011
p1279
sg9
V21304923.xml
p1280
sg11
S'pmed.1000407.PMC3032550.pdf'
p1281
sa(dp1282
g3
g1262
sg5
S'PMC2500037'
p1283
sg7
VSTD-Dicko-2008
p1284
sg9
V18611271.xml
p1285
sg11
S'1475-2875-7-123.PMC2500037.pdf'
p1286
sa(dp1287
g3
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p1288
sg5
S'PMC1974802'
p1289
sg7
VSTD-Sandrini-2007
p1290
sg9
V17627707.xml
p1291
sg11
S'ijcp0061-1256.PMC1974802.pdf'
p1292
sa(dp1293
g3
g1288
sg5
S'PMC3452229'
p1294
sg7
VSTD-Tfelt_x002d_Hansen-2006
p1295
sg9
V17164991.xml
p1296
sg11
S'10194_2006_Article_333.PMC3452229.pdf'
p1297
sa(dp1298
g3
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p1299
sg5
S'PMC3298351'
p1300
sg7
VSTD-Szewczyk-2010
p1301
sg9
V22419941.xml
p1302
sg11
S'AMS-6-5-793.PMC3298351.pdf'
p1303
sa(dp1304
g3
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p1305
sg5
S'PMC3387601'
p1306
sg7
VSTD-El_x002d_Bayoumi-2011
p1307
sg9
V21745374.xml
p1308
sg11
S'cc10305.PMC3387601.pdf'
p1309
sa(dp1310
g3
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p1311
sg5
S'PMC2882846'
p1312
sg7
VSTD-Carlbring-2010
p1313
sg9
V19967577.xml
p1314
sg11
S'sbeh39-92.PMC2882846.pdf'
p1315
sa(dp1316
g3
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p1317
sg5
S'PMC3476149'
p1318
sg7
VSTD-Endres-2007
p1319
sg9
V17955168.xml
p1320
sg11
S'10194_2007_Article_416.PMC3476149.pdf'
p1321
sa(dp1322
g3
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p1323
sg5
S'PMC2366143'
p1324
sg7
VSTD-Watts-1994
p1325
sg9
V18472878.xml
p1326
sg11
S'IDOG-01-220.PMC2366143.pdf'
p1327
sa(dp1328
g3
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p1329
sg5
S'PMC1784771'
p1330
sg7
VSTD-Hibbard-1998
p1331
sg9
V9678143.xml
p1332
sg11
S'9678143.PMC1784771.pdf'
p1333
sa(dp1334
g3
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p1335
sg5
S'PMC2958861'
p1336
sg7
VSTD-Webster-2010a
p1337
sg9
V20937130.xml
p1338
sg11
S'1471-2377-10-92.PMC2958861.pdf'
p1339
sa(dp1340
g3
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p1341
sg5
S'PMC2704535'
p1342
sg7
VSTD-Colin-2007a
p1343
sg9
V19668521.xml
p1344
sg11
S'opth-1-441.PMC2704535.pdf'
p1345
sa(dp1346
g3
g1341
sg5
S'PMC2704535'
p1347
sg7
VSTD-Colin-2007b
p1348
sg9
V19668521.xml
p1349
sg11
S'opth-1-441.PMC2704535.pdf'
p1350
sa(dp1351
g3
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p1352
sg5
S'PMC2395315'
p1353
sg7
VSTD-Albrecht-2004
p1354
sg9
V14710214.xml
p1355
sg11
S'90-6601468a.PMC2395315.pdf'
p1356
sa(dp1357
g3
g1352
sg5
S'PMC1968505'
p1358
sg7
VSTD-Francini-1993
p1359
sg9
V8512828.xml
p1360
sg11
S'brjcancer00208-0270.PMC1968505.pdf'
p1361
sa(dp1362
g3
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p1363
sg5
S'PMC2781155'
p1364
sg7
VSTD-Fan-2009
p1365
sg9
V19666658.xml
p1366
sg11
S'gfp372.PMC2781155.pdf'
p1367
sa(dp1368
g3
g1363
sg5
S'PMC2268719'
p1369
sg7
VSTD-Tzanakis-2008
p1370
sg9
V18193489.xml
p1371
sg11
S'11255_2007_Article_9300.PMC2268719.pdf'
p1372
sa(dp1373
g3
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p1374
sg5
S'PMC2808513'
p1375
sg7
VSTD-Dietz-2010
p1376
sg9
V19834635.xml
p1377
sg11
S'192_2009_Article_1014.PMC2808513.pdf'
p1378
sa(dp1379
g3
g1374
sg5
S'PMC2774153'
p1380
sg7
VSTD-Carey-2009
p1381
sg9
V19583714.xml
p1382
sg11
S'bjo0116-1380.PMC2774153.pdf'
p1383
sa(dp1384
g3
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p1385
sg5
S'PMC2728895'
p1386
sg7
VSTD-Feary-2009a
p1387
sg9
V19400893.xml
p1388
sg11
S'cea0039-1060.PMC2728895.pdf'
p1389
sa(dp1390
g3
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p1391
sg5
S'PMC1904445'
p1392
sg7
VSTD-Perria-2007
p1393
sg9
V17547760.xml
p1394
sg11
S'1472-6963-7-79.PMC1904445.pdf'
p1395
sa(dp1396
g3
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p1397
sg5
S'PMC547907'
p1398
sg7
VSTD-Carey-2005
p1399
sg9
V15667657.xml
p1400
sg11
S'1471-244X-5-5.PMC547907.pdf'
p1401
sa(dp1402
g3
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p1403
sg5
S'PMC3069219'
p1404
sg7
VSTD-Norrkoping
p1405
sg9
V21454449.xml
p1406
sg11
S'bmj.d1539.PMC3069219.pdf'
p1407
sa(dp1408
g3
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p1409
sg5
S'PMC3015270'
p1410
sg7
VSTD-Rosen-1998
p1411
sg9
V9876706.xml
p1412
sg11
S'jsls-2-1-25.PMC3015270.pdf'
p1413
sa(dp1414
g3
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p1415
sg5
S'PMC2000864'
p1416
sg7
VSTD-Willems-2007a
p1417
sg9
V17662113.xml
p1418
sg11
S'1478-7547-5-10.PMC2000864.pdf'
p1419
sa(dp1420
g3
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p1421
sg5
S'PMC1693922'
p1422
sg7
VSTD-Sadighi-2006
p1423
sg9
V17147808.xml
p1424
sg11
S'1471-2407-6-274.PMC1693922.pdf'
p1425
sa(dp1426
g3
g1421
sg5
S'PMC2361806'
p1427
sg7
VSTD-Moehler-2005
p1428
sg9
V15942629.xml
p1429
sg11
S'92-6602649a.PMC2361806.pdf'
p1430
sa(dp1431
g3
g1421
sg5
S'PMC2033628'
p1432
sg7
VSTD-Pyrh_x00f6_nen-1995
p1433
sg9
V7533517.xml
p1434
sg11
S'brjcancer00049-0161.PMC2033628.pdf'
p1435
sa(dp1436
g3
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p1437
sg5
S'PMC2365597'
p1438
sg7
VSTD-de-Benedictis-1994b
p1439
sg9
V18475602.xml
p1440
sg11
S'MI-03-S35.PMC2365597.pdf'
p1441
sa(dp1442
g3
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p1443
sg5
S'PMC2858083'
p1444
sg7
VSTD-Popelut-2010
p1445
sg9
V20422000.xml
p1446
sg11
S'pone.0010274.PMC2858083.pdf'
p1447
sa(dp1448
g3
g1443
sg5
S'PMC1885451'
p1449
sg7
VSTD-Bero-2007
p1450
sg9
V17550302.xml
p1451
sg11
S'pmed.0040184.PMC1885451.pdf'
p1452
sa(dp1453
g3
g1443
sg5
S'PMC126226'
p1454
sg7
VSTD-Clifford-2002
p1455
sg9
V12213183.xml
p1456
sg11
S'1472-6963-2-18.PMC126226.pdf'
p1457
sa(dp1458
g3
g1443
sg5
S'PMC2643439'
p1459
sg7
VSTD-Jefferson-2009
p1460
sg9
V19213766.xml
p1461
sg11
S'bmj.b354.PMC2643439.pdf'
p1462
sa(dp1463
g3
g1443
sg5
S'PMC2811705'
p1464
sg7
VSTD-Rasmussen-2009
p1465
sg9
V20015404.xml
p1466
sg11
S'1745-6215-10-116.PMC2811705.pdf'
p1467
sa(dp1468
g3
g1443
sg5
S'PMC2688752'
p1469
sg7
VSTD-Rattinger-2009
p1470
sg9
V19503811.xml
p1471
sg11
S'pone.0005826.PMC2688752.pdf'
p1472
sa(dp1473
g3
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p1474
sg5
S'PMC2769057'
p1475
sg7
VSTD-Ekeberg-2009
p1476
sg9
V19168537.xml
p1477
sg11
S'bmj.a3112.PMC2769057.pdf'
p1478
sa(dp1479
g3
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p1480
sg5
S'PMC2447617'
p1481
sg7
VSTD-Xiao-2008
p1482
sg9
V18447940.xml
p1483
sg11
S'cc6887.PMC2447617.pdf'
p1484
sa(dp1485
g3
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p1486
sg5
S'PMC523854'
p1487
sg7
VSTD-van-de-Vusse-2004
p1488
sg9
V15453912.xml
p1489
sg11
S'1471-2377-4-13.PMC523854.pdf'
p1490
sa(dp1491
g3
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p1492
sg5
S'PMC3446117'
p1493
sg7
VSTD-Rashidi-2011
p1494
sg9
V23056757.xml
p1495
sg11
S'IJPD-21-008.PMC3446117.pdf'
p1496
sa(dp1497
g3
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p1498
sg5
S'PMC2365597'
p1499
sg7
VSTD-De-Benedictis-1994b
p1500
sg9
V18475602.xml
p1501
sg11
S'MI-03-S35.PMC2365597.pdf'
p1502
sa(dp1503
g3
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p1504
sg5
S'PMC1489930'
p1505
sg7
VSTD-Baradaran-2006
p1506
sg9
V16709243.xml
p1507
sg11
S'1471-2458-6-134.PMC1489930.pdf'
p1508
sa(dp1509
g3
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p1510
sg5
S'PMC1972556'
p1511
sg7
VSTD-Gray-1991
p1512
sg9
V2069842.xml
p1513
sg11
S'brjcancer00214-0009.PMC1972556.pdf'
p1514
sa(dp1515
g3
g1510
sg5
S'PMC2363941'
p1516
sg7
VSTD-Taal-2001
p1517
sg9
V11720425.xml
p1518
sg11
S'85-6692117a.PMC2363941.pdf'
p1519
sa(dp1520
g3
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p1521
sg5
S'PMC2364408'
p1522
sg7
VSTD-Mikamo-_x0028_1_x0029_-1995
p1523
sg9
V18475414.xml
p1524
sg11
S'IDOG-03-007.PMC2364408.pdf'
p1525
sa(dp1526
g3
g1521
sg5
S'PMC1784583'
p1527
sg7
VSTD-Seidman-2005
p1528
sg9
V16338779.xml
p1529
sg11
S'16338779.PMC1784583.pdf'
p1530
sa(dp1531
g3
g1521
sg5
S'PMC2364408'
p1532
sg7
VSTD-Mikamo-_x0028_2_x0029_-1995
p1533
sg9
V18475414.xml
p1534
sg11
S'IDOG-03-007.PMC2364408.pdf'
p1535
sa(dp1536
g3
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p1537
sg5
S'PMC1891438'
p1538
sg7
VSTD-Luabeya-2007
p1539
sg9
V17593956.xml
p1540
sg11
S'pone.0000541.PMC1891438.pdf'
p1541
sa(dp1542
g3
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p1543
sg5
S'PMC2699722'
p1544
sg7
VSTD-O_x0027_Connor-2009
p1545
sg9
V19366977.xml
p1546
sg11
S'zdc1158.PMC2699722.pdf'
p1547
sa(dp1548
g3
g1543
sg5
S'PMC2440309'
p1549
sg7
VSTD-Schneider-2008
p1550
sg9
V18093108.xml
p1551
sg11
S'jep0014-0185.PMC2440309.pdf'
p1552
sa(dp1553
g3
g1543
sg5
S'PMC1868738'
p1554
sg7
VSTD-Foster-2007
p1555
sg9
V17456241.xml
p1556
sg11
S'1471-2296-8-23.PMC1868738.pdf'
p1557
sa(dp1558
g3
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p1559
sg5
S'PMC2442595'
p1560
sg7
VSTD-Hemminki-2008
p1561
sg9
V18547413.xml
p1562
sg11
S'1472-6963-8-126.PMC2442595.pdf'
p1563
sa(dp1564
g3
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p1565
sg5
S'PMC2717432'
p1566
sg7
VSTD-Kneyber-2009
p1567
sg9
V19450268.xml
p1568
sg11
S'cc7880.PMC2717432.pdf'
p1569
sa(dp1570
g3
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p1571
sg5
S'PMC2364281'
p1572
sg7
VSTD-Razavi-2002
p1573
sg9
V12085247.xml
p1574
sg11
S'87-6600412a.PMC2364281.pdf'
p1575
sa(dp1576
g3
g1571
sg5
S'PMC2906741'
p1577
sg7
VSTD-Lienard-2010
p1578
sg9
V20628395.xml
p1579
sg11
S'6605749a.PMC2906741.pdf'
p1580
sa(dp1581
g3
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p1582
sg5
S'PMC1552064'
p1583
sg7
VSTD-Elsinga-2006
p1584
sg9
V16824233.xml
p1585
sg11
S'1471-2296-7-41.PMC1552064.pdf'
p1586
sa(dp1587
g3
g1582
sg5
S'PMC1712341'
p1588
sg7
VSTD-Lumley-2006
p1589
sg9
V17156466.xml
p1590
sg11
S'1471-2458-6-299.PMC1712341.pdf'
p1591
sa(dp1592
g3
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p1593
sg5
S'PMC3043413'
p1594
sg7
VSTD-Reis-Neto-2002
p1595
sg9
V12113422.xml
p1596
sg11
S'jsls-6-2-163.PMC3043413.pdf'
p1597
sa(dp1598
g3
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p1599
sg5
S'PMC2794266'
p1600
sg7
VSTD-BRAIN-2009
p1601
sg9
V19958521.xml
p1602
sg11
S'1745-6215-10-109.PMC2794266.pdf'
p1603
sa(dp1604
g3
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p1605
sg5
S'PMC2033710'
p1606
sg7
VSTD-Riccardi-1994
p1607
sg9
V7981078.xml
p1608
sg11
S'brjcancer00058-0171.PMC2033710.pdf'
p1609
sa(dp1610
g3
g1605
sg5
S'PMC2374495'
p1611
sg7
VSTD-Riccardi-2000
p1612
sg9
V10755397.xml
p1613
sg11
S'82-6691087a.PMC2374495.pdf'
p1614
sa(dp1615
g3
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p1616
sg5
S'PMC1968186'
p1617
sg7
VSTD-Fraser-S-1993
p1618
sg9
V8431375.xml
p1619
sg11
S'brjcancer00204-0200.PMC1968186.pdf'
p1620
sa(dp1621
g3
g1616
sg5
S'PMC2025018'
p1622
sg7
VSTD-Rubens-RD-1975
p1623
sg9
V766800.xml
p1624
sg11
S'brjcancer00321-0094.PMC2025018.pdf'
p1625
sa(dp1626
g3
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p1627
sg5
S'PMC3084519'
p1628
sg7
VSTD-LEAD_x002d_3-2006
p1629
sg9
V21205128.xml
p1630
sg11
S'dom0013-0348.PMC3084519.pdf'
p1631
sa(dp1632
g3
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p1633
sg5
S'PMC2644301'
p1634
sg7
VSTD-Calverley-2008
p1635
sg9
V19014549.xml
p1636
sg11
S'1465-9921-9-73.PMC2644301.pdf'
p1637
sa(dp1638
g3
g1633
sg5
S'PMC2793071'
p1639
sg7
VSTD-Schermer-2009
p1640
sg9
V20037682.xml
p1641
sg11
S'copd-4-431.PMC2793071.pdf'
p1642
sa(dp1643
g3
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p1644
sg5
S'PMC2690844'
p1645
sg7
VSTD-Halm-2009
p1646
sg9
V19259615.xml
p1647
sg11
S'10029_2008_Article_469.PMC2690844.pdf'
p1648
sa(dp1649
g3
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p1650
sg5
S'PMC2409363'
p1651
sg7
VSTD-Matsegui-2008
p1652
sg9
V18503714.xml
p1653
sg11
S'1475-2875-7-91.PMC2409363.pdf'
p1654
sa(dp1655
g3
g1650
sg5
S'PMC3123603'
p1656
sg7
VSTD-Kofoed-2011
p1657
sg9
V21631932.xml
p1658
sg11
S'1475-2875-10-148.PMC3123603.pdf'
p1659
sa(dp1660
g3
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p1661
sg5
S'PMC2253708'
p1662
sg7
VSTD-Meyer-2008
p1663
sg9
V17995993.xml
p1664
sg11
S'add0103-0294.PMC2253708.pdf'
p1665
sa(dp1666
g3
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p1667
sg5
S'PMC2361635'
p1668
sg7
VSTD-Donskov_x0028_ii_x0029_-2005
p1669
sg9
V16136045.xml
p1670
sg11
S'93-6602768a.PMC2361635.pdf'
p1671
sa(dp1672
g3
g1667
sg5
S'PMC2063040'
p1673
sg7
VSTD-Jayson-1998
p1674
sg9
V9703284.xml
p1675
sg11
S'brjcancer00003-0090.PMC2063040.pdf'
p1676
sa(dp1677
g3
g1667
sg5
S'PMC2033601'
p1678
sg7
VSTD-DeMulder-1995
p1679
sg9
V7841054.xml
p1680
sg11
S'brjcancer00048-0159.PMC2033601.pdf'
p1681
sa(dp1682
g3
g1667
sg5
S'PMC2361635'
p1683
sg7
VSTD-Donskov_x0028_i_x0029_-2005
p1684
sg9
V16136045.xml
p1685
sg11
S'93-6602768a.PMC2361635.pdf'
p1686
sa(dp1687
g3
g1667
sg5
S'PMC2150170'
p1688
sg7
VSTD-Henriksson-1998
p1689
sg9
V9579838.xml
p1690
sg11
S'brjcancer00084-0117.PMC2150170.pdf'
p1691
sa(dp1692
g3
g1667
sg5
S'PMC2375150'
p1693
sg7
VSTD-Atzpodien-2001
p1694
sg9
V11710825.xml
p1695
sg11
S'85-6692076a.PMC2375150.pdf'
p1696
sa(dp1697
g3
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p1698
sg5
S'PMC1920547'
p1699
sg7
VSTD-COMPASS
p1700
sg9
V17362472.xml
p1701
sg11
S'ijcp0061-0725.PMC1920547.pdf'
p1702
sa(dp1703
g3
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p1704
sg5
S'PMC2639265'
p1705
sg7
VSTD-McMurdo-2009
p1706
sg9
V19042940.xml
p1707
sg11
S'dkn489.PMC2639265.pdf'
p1708
sa(dp1709
g3
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p1710
sg5
S'PMC2268921'
p1711
sg7
VSTD-Young-2008
p1712
sg9
V18304363.xml
p1713
sg11
S'1471-2296-9-16.PMC2268921.pdf'
p1714
sa(dp1715
g3
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p1716
sg5
S'PMC1904466'
p1717
sg7
VSTD-Fretheim-2007
p1718
sg9
V17622192.xml
p1719
sg11
S'pmed.0040232.PMC1904466.pdf'
p1720
sa(dp1721
g3
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p1722
sg5
S'PMC2206510'
p1723
sg7
VSTD-Lee-2007
p1724
sg9
V17705879.xml
p1725
sg11
S'cc5976.PMC2206510.pdf'
p1726
sa(dp1727
g3
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p1728
sg5
S'PMC2997603'
p1729
sg7
VSTD-Fagerstrom-2010
p1730
sg9
V21134997.xml
p1731
sg11
S'bmj.c6549.PMC2997603.pdf'
p1732
sa(dp1733
g3
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p1734
sg5
S'PMC1831486'
p1735
sg7
VSTD-White-2007
p1736
sg9
V17359519.xml
p1737
sg11
S'1472-6882-7-8.PMC1831486.pdf'
p1738
sa(dp1739
g3
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p1740
sg5
S'PMC1891438'
p1741
sg7
VSTD-Luabeya-2007
p1742
sg9
V17593956.xml
p1743
sg11
S'pone.0000541.PMC1891438.pdf'
p1744
sa(dp1745
g3
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p1746
sg5
S'PMC2074537'
p1747
sg7
VSTD-Mohide-1996
p1748
sg9
V8664135.xml
p1749
sg11
S'brjcancer00040-0138.PMC2074537.pdf'
p1750
sa(dp1751
g3
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p1752
sg5
S'PMC2364680'
p1753
sg7
VSTD-Hemsell-1993
p1754
sg9
V18476202.xml
p1755
sg11
S'IDOG-01-027.PMC2364680.pdf'
p1756
sa(dp1757
g3
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p1758
sg5
S'PMC2615351'
p1759
sg7
VSTD-Leykin-2008
p1760
sg9
V18581586.xml
p1761
sg11
S'ymj-49-383.PMC2615351.pdf'
p1762
sa(dp1763
g3
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p1764
sg5
S'PMC111183'
p1765
sg7
VSTD-Totapally-2002
p1766
sg9
V11983043.xml
p1767
sg11
S'cc-6-2-160.PMC111183.pdf'
p1768
sa(dp1769
g3
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p1770
sg5
S'PMC3113983'
p1771
sg7
VSTD-Dent-2011
p1772
sg9
V21542934.xml
p1773
sg11
S'1745-6215-12-109.PMC3113983.pdf'
p1774
sa(dp1775
g3
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p1776
sg5
S'PMC2741110'
p1777
sg7
VSTD-Smith-2003
p1778
sg9
V12799626.xml
p1779
sg11
S'88-6600994a.PMC2741110.pdf'
p1780
sa(dp1781
g3
g1776
sg5
S'PMC2376376'
p1782
sg7
VSTD-Boogaerts-2003
p1783
sg9
V12671693.xml
p1784
sg11
S'88-6600801a.PMC2376376.pdf'
p1785
sa(dp1786
g3
g1776
sg5
S'PMC2362337'
p1787
sg7
VSTD-Thatcher-1999
p1788
sg9
V10408844.xml
p1789
sg11
S'80-6690369a.PMC2362337.pdf'
p1790
sa(dp1791
g3
g1776
sg5
S'PMC2361228'
p1792
sg7
VSTD-Wilkinson-2006
p1793
sg9
V16570051.xml
p1794
sg11
S'94-6603004a.PMC2361228.pdf'
p1795
sa(dp1796
g3
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p1797
sg5
S'PMC2773536'
p1798
sg7
VSTD-Madlung_x002d_Kratzer-2009
p1799
sg9
V19686525.xml
p1800
sg11
S'add0104-1549.PMC2773536.pdf'
p1801
sa(dp1802
g3
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p1803
sg5
S'PMC2724738'
p1804
sg7
VSTD-Carling-2009
p1805
sg9
V19707575.xml
p1806
sg11
S'pmed.1000134.PMC2724738.pdf'
p1807
sa(dp1808
g3
g1803
sg5
S'PMC2585274'
p1809
sg7
VSTD-Carling-2008
p1810
sg9
V19030110.xml
p1811
sg11
S'pone.0003693.PMC2585274.pdf'
p1812
sa(dp1813
g3
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p1814
sg5
S'PMC3446002'
p1815
sg7
VSTD-Sharafi-2010
p1816
sg9
V23056681.xml
p1817
sg11
S'IJPD-20-048.PMC3446002.pdf'
p1818
sa(dp1819
g3
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p1820
sg5
S'PMC1750976'
p1821
sg7
VSTD-Lorente-2006
p1822
sg9
V16884530.xml
p1823
sg11
S'cc5009.PMC1750976.pdf'
p1824
sa(dp1825
g3
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p1826
sg5
S'PMC2653746'
p1827
sg7
VSTD-Vodermaier-2009
p1828
sg9
V19209172.xml
p1829
sg11
S'6604916a.PMC2653746.pdf'
p1830
sa(dp1831
g3
g1826
sg5
S'PMC1626460'
p1832
sg7
VSTD-Sheridan-2006
p1833
sg9
V17005051.xml
p1834
sg11
S'1472-6963-6-121.PMC1626460.pdf'
p1835
sa(dp1836
g3
g1826
sg5
S'PMC1781432'
p1837
sg7
VSTD-Thomson-2007
p1838
sg9
V17214891.xml
p1839
sg11
S'1472-6947-7-2.PMC1781432.pdf'
p1840
sa(dp1841
g3
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p1842
sg5
S'PMC2360384'
p1843
sg7
VSTD-Hutchison-2007
p1844
sg9
V17848908.xml
p1845
sg11
S'6603943a.PMC2360384.pdf'
p1846
sa(dp1847
g3
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p1848
sg5
S'PMC2963502'
p1849
sg7
VSTD-RESOLVE
p1850
sg9
V20980427.xml
p1851
sg11
S'zdc2399.PMC2963502.pdf'
p1852
sa(dp1853
g3
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p1854
sg5
S'PMC1977824'
p1855
sg7
VSTD-Dixon-1992
p1856
sg9
V1503915.xml
p1857
sg11
S'brjcancer00060-0180.PMC1977824.pdf'
p1858
sa(dp1859
g3
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p1860
sg5
S'PMC2612742'
p1861
sg7
VSTD-Brookfield-2009
p1862
sg9
V19125205.xml
p1863
sg11
S'pone.0004049.PMC2612742.pdf'
p1864
sa(dp1865
g3
g1860
sg5
S'PMC2363169'
p1866
sg7
VSTD-Stockton-2000
p1867
sg9
V10638991.xml
p1868
sg11
S'82-6690901a.PMC2363169.pdf'
p1869
sa(dp1870
g3
VCD006777 v. 3.0 Framing of health information messages.rm5
p1871
sg5
S'PMC2830888'
p1872
sg7
VSTD-Carling-2010
p1873
sg9
V20209127.xml
p1874
sg11
S'pone.0009469.PMC2830888.pdf'
p1875
sa(dp1876
g3
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p1877
sg5
S'PMC2636685'
p1878
sg7
VSTD-MacArthur-2009
p1879
sg9
V19181730.xml
p1880
sg11
S'bmj.b131.PMC2636685.pdf'
p1881
sa(dp1882
g3
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p1883
sg5
S'PMC1891439'
p1884
sg7
VSTD-Pandit-2007-NPL
p1885
sg9
V17593957.xml
p1886
sg11
S'pone.0000542.PMC1891439.pdf'
p1887
sa(dp1888
g3
g1883
sg5
S'PMC2374894'
p1889
sg7
VSTD-Dolecek-2008-VNM
p1890
sg9
V18493312.xml
p1891
sg11
S'pone.0002188.PMC2374894.pdf'
p1892
sa(dp1893
g3
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p1894
sg5
S'PMC3022338'
p1895
sg7
VSTD-Thunander-2010
p1896
sg9
V21088056.xml
p1897
sg11
S'EJE100901.PMC3022338.pdf'
p1898
sa(dp1899
g3
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p1900
sg5
S'PMC3090298'
p1901
sg7
VSTD-Hatch-2011
p1902
sg9
V21573091.xml
p1903
sg11
S'opth-5-451.PMC3090298.pdf'
p1904
sa(dp1905
g3
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p1906
sg5
S'PMC2696321'
p1907
sg7
VSTD-Eddleston-2009
p1908
sg9
V19564902.xml
p1909
sg11
S'pmed.1000104.PMC2696321.pdf'
p1910
sa(dp1911
g3
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p1912
sg5
S'PMC2712451'
p1913
sg7
VSTD-Ried-2009
p1914
sg9
V19583878.xml
p1915
sg11
S'1472-6882-9-22.PMC2712451.pdf'
p1916
sa(dp1917
g3
g1912
sg5
S'PMC2270716'
p1918
sg7
VSTD-Fraga-2005
p1919
sg9
V15712594.xml
p1920
sg11
S'CDI-12-011.PMC2270716.pdf'
p1921
sa(dp1922
g3
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p1923
sg5
S'PMC1475568'
p1924
sg7
VSTD-DeWalt-2006
p1925
sg9
V16533388.xml
p1926
sg11
S'1472-6963-6-30.PMC1475568.pdf'
p1927
sa(dp1928
g3
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p1929
sg5
S'PMC2767482'
p1930
sg7
VSTD-Martins-2009
p1931
sg9
V19858174.xml
p1932
sg11
S'bmj.b4248.PMC2767482.pdf'
p1933
sa(dp1934
g3
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p1935
sg5
S'PMC3109952'
p1936
sg7
VSTD-Cockayne-2011
p1937
sg9
V21652750.xml
p1938
sg11
S'bmj.d3271.PMC3109952.pdf'
p1939
sa(dp1940
g3
g1935
sg5
S'PMC2703213'
p1941
sg7
VSTD-Fuchs-2004
p1942
sg9
V19675691.xml
p1943
sg11
S'GMS-02-08.PMC2703213.pdf'
p1944
sa(dp1945
g3
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p1946
sg5
S'PMC2408916'
p1947
sg7
VSTD-TXT-Group
p1948
sg9
V12439707.xml
p1949
sg11
S'87-6600645a.PMC2408916.pdf'
p1950
sa(dp1951
g3
g1946
sg5
S'PMC2375384'
p1952
sg7
VSTD-Talbot
p1953
sg9
V11986765.xml
p1954
sg11
S'86-6600261a.PMC2375384.pdf'
p1955
sa(dp1956
g3
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p1957
sg5
S'PMC2649916'
p1958
sg7
VSTD-Lindell-2008
p1959
sg9
V19116007.xml
p1960
sg11
S'1471-2474-9-172.PMC2649916.pdf'
p1961
sa(dp1962
g3
VCD004843 v. 10.2 Music for pain relief.rm5
p1963
sg5
S'PMC2362603'
p1964
sg7
VSTD-Kotwal-1998
p1965
sg9
V18493472.xml
p1966
sg11
S'DTE-04-191.PMC2362603.pdf'
p1967
sa(dp1968
g3
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p1969
sg5
S'PMC3580134'
p1970
sg7
VSTD-Rennard-2009
p1971
sg9
V19368417.xml
p1972
sg11
S'40265_2012_Article_69050549.PMC3580134.pdf'
p1973
sa(dp1974
g3
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p1975
sg5
S'PMC2360523'
p1976
sg7
VSTD-Aranda-2006
p1977
sg9
V16967054.xml
p1978
sg11
S'95-6603320a.PMC2360523.pdf'
p1979
sa(dp1980
g3
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p1981
sg5
S'PMC2556688'
p1982
sg7
VSTD-Jones-2008
p1983
sg9
V18718012.xml
p1984
sg11
S'1479-5868-5-42.PMC2556688.pdf'
p1985
sa(dp1986
g3
g1981
sg5
S'PMC2827713'
p1987
sg7
VSTD-Kriemler-2010
p1988
sg9
V20179126.xml
p1989
sg11
S'bmj.c785.PMC2827713.pdf'
p1990
sa(dp1991
g3
g1981
sg5
S'PMC2758893'
p1992
sg7
VSTD-Gentile-2009
p1993
sg9
V19765270.xml
p1994
sg11
S'1741-7015-7-49.PMC2758893.pdf'
p1995
sa(dp1996
g3
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p1997
sg5
S'PMC2265283'
p1998
sg7
VSTD-Poikolainen-2008
p1999
sg9
V18218147.xml
p2000
sg11
S'1747-597X-3-1.PMC2265283.pdf'
p2001
sa(dp2002
g3
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p2003
sg5
S'PMC1472695'
p2004
sg7
VSTD-Fretheim-2006
p2005
sg9
V16737346.xml
p2006
sg11
S'pmed.0030134.PMC1472695.pdf'
p2007
sa(dp2008
g3
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p2009
sg5
S'PMC2363881'
p2010
sg7
VSTD-Cameron-2001
p2011
sg9
V11379605.xml
p2012
sg11
S'84-6691623a.PMC2363881.pdf'
p2013
sa(dp2014
g3
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p2015
sg5
S'PMC548524'
p2016
sg7
VSTD-Keiser-2005
p2017
sg9
V15647105.xml
p2018
sg11
S'1471-2334-5-2.PMC548524.pdf'
p2019
sa(dp2020
g3
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p2021
sg5
S'PMC222984'
p2022
sg7
VSTD-Veldt-2003
p2023
sg9
V12948399.xml
p2024
sg11
S'1471-230X-3-24.PMC222984.pdf'
p2025
sa(dp2026
g3
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p2027
sg5
S'PMC2660391'
p2028
sg7
VSTD-O_x0027_Sullivan-2009
p2029
sg9
V19318702.xml
p2030
sg11
S'bmj.b784.PMC2660391.pdf'
p2031
sa(dp2032
g3
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p2033
sg5
S'PMC3002764'
p2034
sg7
VSTD-MAINTAIN-Nephritis-Study
p2035
sg9
V20833738.xml
p2036
sg11
S'ard-69-12-2083.PMC3002764.pdf'
p2037
sa(dp2038
g3
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p2039
sg5
S'PMC2680945'
p2040
sg7
VSTD-Charles-2009
p2041
sg9
V19435763.xml
p2042
sg11
S'bmj.b1732.PMC2680945.pdf'
p2043
sa(dp2044
g3
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p2045
sg5
S'PMC2634726'
p2046
sg7
VSTD-Neuhaus-2009
p2047
sg9
V19127261.xml
p2048
sg11
S'6604835a.PMC2634726.pdf'
p2049
sa(dp2050
g3
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p2051
sg5
S'PMC2362097'
p2052
sg7
VSTD-MAM-01-GOCSI
p2053
sg9
V15668708.xml
p2054
sg11
S'92-6602355a.PMC2362097.pdf'
p2055
sa(dp2056
g3
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p2057
sg5
S'PMC3041931'
p2058
sg7
VSTD-Pakistan-2011
p2059
sg9
V21176086.xml
p2060
sg11
S'bjo0118-0353.PMC3041931.pdf'
p2061
sa(dp2062
g3
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p2063
sg5
S'PMC2924475'
p2064
sg7
VSTD-Chen-2010
p2065
sg9
V20724402.xml
p2066
sg11
S'bmj.c4024.PMC2924475.pdf'
p2067
sa(dp2068
g3
g2063
sg5
S'PMC3172444'
p2069
sg7
VSTD-Channabasavanna-1987
p2070
sg9
V21927264.xml
p2071
sg11
S'IJPsy-29-333.PMC3172444.pdf'
p2072
sa(dp2073
g3
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p2074
sg5
S'PMC2223944'
p2075
sg7
VSTD-Pyrhonen-1997
p2076
sg9
V9231932.xml
p2077
sg11
S'brjcancer00166-0134.PMC2223944.pdf'
p2078
sa(dp2079
g3
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p2080
sg5
S'PMC2687544'
p2081
sg7
VSTD-Chirico-2009
p2082
sg9
V19490659.xml
p2083
sg11
S'1824-7288-35-4.PMC2687544.pdf'
p2084
sa(dp2085
g3
g2080
sg5
S'PMC2816247'
p2086
sg7
VSTD-Nuijten-2010
p2087
sg9
V19967425.xml
p2088
sg11
S'10198_2009_Article_206.PMC2816247.pdf'
p2089
sa(dp2090
g3
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p2091
sg5
S'PMC2730258'
p2092
sg7
VSTD-Colford-2002
p2093
sg9
V11749745.xml
p2094
sg11
S'00-1481_FinalR.PMC2730258.pdf'
p2095
sa(dp2096
g3
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p2097
sg5
S'PMC2147028'
p2098
sg7
VSTD-Namutangula-2007
p2099
sg9
V17958887.xml
p2100
sg11
S'1475-2875-6-138.PMC2147028.pdf'
p2101
sa(dp2102
g3
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p2103
sg5
S'PMC2681027'
p2104
sg7
VSTD-Rosenson-2009
p2105
sg9
V19265025.xml
p2106
sg11
S'zdc1087.PMC2681027.pdf'
p2107
sa(dp2108
g3
g2103
sg5
S'PMC2829413'
p2109
sg7
VSTD-Park-2010
p2110
sg9
V20195400.xml
p2111
sg11
S'kjim-25-27.PMC2829413.pdf'
p2112
sa(dp2113
g3
g2103
sg5
S'PMC3079135'
p2114
sg7
VSTD-Cho-2011
p2115
sg9
V21519514.xml
p2116
sg11
S'kcj-41-149.PMC3079135.pdf'
p2117
sa(dp2118
g3
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p2119
sg5
S'PMC3198285'
p2120
sg7
VSTD-Louie-2011
p2121
sg9
V21900148.xml
p2122
sg11
S'2341.PMC3198285.pdf'
p2123
sa(dp2124
g3
g2119
sg5
S'PMC2681032'
p2125
sg7
VSTD-Moses-2009
p2126
sg9
V19279301.xml
p2127
sg11
S'zdc996.PMC2681032.pdf'
p2128
sa(dp2129
g3
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p2130
sg5
S'PMC2628928'
p2131
sg7
VSTD-Del-Giglio-2008
p2132
sg9
V19014494.xml
p2133
sg11
S'1471-2407-8-332.PMC2628928.pdf'
p2134
sa(dp2135
g3
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p2136
sg5
S'PMC1885369'
p2137
sg7
VSTD-Bakker-2007
p2138
sg9
V17549228.xml
p2139
sg11
S'pctr.0020026.PMC1885369.pdf'
p2140
sa(dp2141
g3
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p2142
sg5
S'PMC2826100'
p2143
sg7
VSTD-Oh-2010
p2144
sg9
V19880433.xml
p2145
sg11
S'mdp479.PMC2826100.pdf'
p2146
sa(dp2147
g3
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p2148
sg5
S'PMC1087200'
p2149
sg7
VSTD-Sutherland-2005
p2150
sg9
V15839740.xml
p2151
sg11
S'pmed.0020092.PMC1087200.pdf'
p2152
sa(dp2153
g3
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p2154
sg5
S'PMC1502073'
p2155
sg7
VSTD-Eslami-2005
p2156
sg9
V16943938.xml
p2157
sg11
S'ipej050005-00.PMC1502073.pdf'
p2158
sa(dp2159
g3
g2154
sg5
S'PMC3034455'
p2160
sg7
VSTD-Chavan-2010
p2161
sg9
V21358799.xml
p2162
sg11
S'ipej100529-00.PMC3034455.pdf'
p2163
sa(dp2164
g3
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p2165
sg5
S'PMC2886041'
p2166
sg7
VSTD-FACS-2010
p2167
sg9
V20500832.xml
p2168
sg11
S'1745-6215-11-61.PMC2886041.pdf'
p2169
sa(dp2170
g3
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p2171
sg5
S'PMC1698486'
p2172
sg7
VSTD-Sims-2006
p2173
sg9
V17134517.xml
p2174
sg11
S'1471-2318-6-18.PMC1698486.pdf'
p2175
sa(dp2176
g3
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p2177
sg5
S'PMC2206502'
p2178
sg7
VSTD-Kluger-2007
p2179
sg9
V17686152.xml
p2180
sg11
S'cc6092.PMC2206502.pdf'
p2181
sa(dp2182
g3
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p2183
sg5
S'PMC116603'
p2184
sg7
VSTD-Sheikh-2002
p2185
sg9
V12079502.xml
p2186
sg11
S'1471-2296-3-12.PMC116603.pdf'
p2187
sa(dp2188
g3
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p2189
sg5
S'PMC406425'
p2190
sg7
VSTD-Sokal-2004
p2191
sg9
V15056388.xml
p2192
sg11
S'1741-7015-2-6.PMC406425.pdf'
p2193
sa(dp2194
g3
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p2195
sg5
S'PMC2899760'
p2196
sg7
VSTD-Lofgren-2010
p2197
sg9
V19763634.xml
p2198
sg11
S'586_2009_Article_1161.PMC2899760.pdf'
p2199
sa(dp2200
g3
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p2201
sg5
S'PMC1971367'
p2202
sg7
VSTD-Southampton
p2203
sg9
V1691921.xml
p2204
sg11
S'brjcancer00224-0118.PMC1971367.pdf'
p2205
sa(dp2206
g3
g2201
sg5
S'PMC1971367'
p2207
sg7
VSTD-RLW-8351
p2208
sg9
V1691921.xml
p2209
sg11
S'brjcancer00224-0118.PMC1971367.pdf'
p2210
sa(dp2211
g3
g2201
sg5
S'PMC2374661'
p2212
sg7
VSTD-Manchester-1
p2213
sg9
V10945489.xml
p2214
sg11
S'83-6691307a.PMC2374661.pdf'
p2215
sa(dp2216
g3
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p2217
sg5
S'PMC2364502'
p2218
sg7
VSTD-Charleston-1996
p2219
sg9
V18476110.xml
p2220
sg11
S'IDOG-04-294.PMC2364502.pdf'
p2221
sa(dp2222
g3
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p2223
sg5
S'PMC2687520'
p2224
sg7
VSTD-Lim-2009
p2225
sg9
V19169651.xml
p2226
sg11
S'11060_2008_Article_9781.PMC2687520.pdf'
p2227
sa(dp2228
g3
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p2229
sg5
S'PMC2268695'
p2230
sg7
VSTD-Itoh-2008
p2231
sg9
V18312661.xml
p2232
sg11
S'1749-8546-3-2.PMC2268695.pdf'
p2233
sa(dp2234
g3
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p2235
sg5
S'PMC2453657'
p2236
sg7
VSTD-Charron_x002d_Prochownik-2008
p2237
sg9
V18411239.xml
p2238
sg11
S'1327.PMC2453657.pdf'
p2239
sa(dp2240
g3
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p2241
sg5
S'PMC2365805'
p2242
sg7
VSTD-Ringdal-1996
p2243
sg9
V18475734.xml
p2244
sg11
S'MI-05-382.PMC2365805.pdf'
p2245
sa(dp2246
g3
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p2247
sg5
S'PMC2494667'
p2248
sg7
VSTD-Fonseca-2008
p2249
sg9
V18458145.xml
p2250
sg11
S'1479.PMC2494667.pdf'
p2251
sa(dp2252
g3
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p2253
sg5
S'PMC2360162'
p2254
sg7
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p2255
sg9
V17375049.xml
p2256
sg11
S'6603686a.PMC2360162.pdf'
p2257
sa(dp2258
g3
g2253
sg5
S'PMC2363941'
p2259
sg7
VSTD-Taal-2001-_x0028_NACCP_x0029_
p2260
sg9
V11720425.xml
p2261
sg11
S'85-6692117a.PMC2363941.pdf'
p2262
sa(dp2263
g3
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p2264
sg5
S'PMC2825497'
p2265
sg7
VSTD-Leon-2010
p2266
sg9
V20205841.xml
p2267
sg11
S'1748-5908-5-8.PMC2825497.pdf'
p2268
sa(dp2269
g3
g2264
sg5
S'PMC1831737'
p2270
sg7
VSTD-Gregson-2007
p2271
sg9
V17388666.xml
p2272
sg11
S'pmed.0040102.PMC1831737.pdf'
p2273
sa(dp2274
g3
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p2275
sg5
S'PMC2875437'
p2276
sg7
VSTD-Lorig-2010
p2277
sg9
V20299481.xml
p2278
sg11
S'zdc1275.PMC2875437.pdf'
p2279
sa(dp2280
g3
g2275
sg5
S'PMC3161305'
p2281
sg7
VSTD-Quinn-2011
p2282
sg9
V21788632.xml
p2283
sg11
S'1934.PMC3161305.pdf'
p2284
sa(dp2285
g3
g2275
sg5
S'PMC3024339'
p2286
sg7
VSTD-Lim-2011
p2287
sg9
V21270188.xml
p2288
sg11
S'308.PMC3024339.pdf'
p2289
sa(dp2290
g3
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p2291
sg5
S'PMC1871574'
p2292
sg7
VSTD-Binnie-2007
p2293
sg9
V17475005.xml
p2294
sg11
S'1472-6831-7-5.PMC1871574.pdf'
p2295
sa(dp2296
g3
g2291
sg5
S'PMC2685131'
p2297
sg7
VSTD-Nohlert-2009
p2298
sg9
V19405969.xml
p2299
sg11
S'1471-2458-9-121.PMC2685131.pdf'
p2300
sa(dp2301
g3
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p2302
sg5
S'PMC2361560'
p2303
sg7
VSTD-van-Sprundel-2005
p2304
sg9
V16052221.xml
p2305
sg11
S'93-6602703a.PMC2361560.pdf'
p2306
sa(dp2307
g3
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p2308
sg5
S'PMC2906750'
p2309
sg7
VSTD-Merenstein-2010
p2310
sg9
V20485304.xml
p2311
sg11
S'ejcn201065a.PMC2906750.pdf'
p2312
sa(dp2313
g3
g2308
sg5
S'PMC3083335'
p2314
sg7
VSTD-West-2011
p2315
sg9
V21477383.xml
p2316
sg11
S'1475-2891-10-30.PMC3083335.pdf'
p2317
sa(dp2318
g3
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p2319
sg5
S'PMC2396289'
p2320
sg7
VSTD-Mahalanabis-2008
p2321
sg9
V18523643.xml
p2322
sg11
S'pone.0002323.PMC2396289.pdf'
p2323
sa(dp2324
g3
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p2325
sg5
S'PMC3446875'
p2326
sg7
VSTD-UK-PRECISE
p2327
sg9
V23028897.xml
p2328
sg11
S'pone.0045269.PMC3446875.pdf'
p2329
sa(dp2330
g3
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p2331
sg5
S'PMC1262556'
p2332
sg7
VSTD-ANRS-1265
p2333
sg9
V16231970.xml
p2334
sg11
S'pmed.0020298.PMC1262556.pdf'
p2335
sa(dp2336
g3
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p2337
sg5
S'PMC3012941'
p2338
sg7
VSTD-Dube-1981
p2339
sg9
V22058537.xml
p2340
sg11
S'IJPsy-23-193.PMC3012941.pdf'
p2341
sa(dp2342
g3
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p2343
sg5
S'PMC1920547'
p2344
sg7
VSTD-Kuna-2007
p2345
sg9
V17362472.xml
p2346
sg11
S'ijcp0061-0725.PMC1920547.pdf'
p2347
sa(dp2348
g3
g2343
sg5
S'PMC2993043'
p2349
sg7
VSTD-Maspero-2010
p2350
sg9
V20874458.xml
p2351
sg11
S'ljas47-1106.PMC2993043.pdf'
p2352
sa(dp2353
g3
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p2354
sg5
S'PMC2246206'
p2355
sg7
VSTD-Jimenez-2007
p2356
sg9
V17988379.xml
p2357
sg11
S'cc6173.PMC2246206.pdf'
p2358
sa(dp2359
g3
g2354
sg5
S'PMC2287179'
p2360
sg7
VSTD-Apostolakis-2008
p2361
sg9
V18361800.xml
p2362
sg11
S'1749-8090-3-14.PMC2287179.pdf'
p2363
sa(dp2364
g3
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p2365
sg5
S'PMC3177872'
p2366
sg7
VSTD-Peng-2011
p2367
sg9
V21835046.xml
p2368
sg11
S'1748-717X-6-93.PMC3177872.pdf'
p2369
sa(dp2370
g3
g2365
sg5
S'PMC2363346'
p2371
sg7
VSTD-Allal-2000
p2372
sg9
V10735495.xml
p2373
sg11
S'82-6691052a.PMC2363346.pdf'
p2374
sa(dp2375
g3
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p2376
sg5
S'PMC2770592'
p2377
sg7
VSTD-SPHERE
p2378
sg9
V19875426.xml
p2379
sg11
S'bmj.b4220.PMC2770592.pdf'
p2380
sa(dp2381
g3
VCD004366 v. 11.2 Exercise for depression.rm5
p2382
sg5
S'PMC1976311'
p2383
sg7
VSTD-Pilu-2007
p2384
sg9
V17620123.xml
p2385
sg11
S'1745-0179-3-8.PMC1976311.pdf'
p2386
sa(dp2387
g3
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p2388
sg5
S'PMC3219630'
p2389
sg7
VSTD-Chaney-2011
p2390
sg9
V22032247.xml
p2391
sg11
S'1748-5908-6-121.PMC3219630.pdf'
p2392
sa(dp2393
g3
g2388
sg5
S'PMC1838423'
p2394
sg7
VSTD-Landis-2007
p2395
sg9
V17338822.xml
p2396
sg11
S'1471-2296-8-7.PMC1838423.pdf'
p2397
sa(dp2398
g3
g2388
sg5
S'PMC2770465'
p2399
sg7
VSTD-Richards-2012
p2400
sg9
V19832996.xml
p2401
sg11
S'1472-6963-9-188.PMC2770465.pdf'
p2402
sa(dp2403
g3
g2388
sg5
S'PMC3051073'
p2404
sg7
VSTD-Waitzkin-2011
p2405
sg9
V20882400.xml
p2406
sg11
S'10900_2010_Article_9313.PMC3051073.pdf'
p2407
sa(dp2408
g3
g2388
sg5
S'PMC2845010'
p2409
sg7
VSTD-Ell-2010
p2410
sg9
V20097780.xml
p2411
sg11
S'zdc706.PMC2845010.pdf'
p2412
sa(dp2413
g3
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p2414
sg5
S'PMC125315'
p2415
sg7
VSTD-Yildiz-2002
p2416
sg9
V12133187.xml
p2417
sg11
S'cc1498.PMC125315.pdf'
p2418
sa(dp2419
g3
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p2420
sg5
S'PMC3015970'
p2421
sg7
VSTD-Uludag-2009
p2422
sg9
V19793473.xml
p2423
sg11
S'jsls-13-3-337.PMC3015970.pdf'
p2424
sa(dp2425
g3
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p2426
sg5
S'PMC2797495'
p2427
sg7
VSTD-Spittle-2009a
p2428
sg9
V19954550.xml
p2429
sg11
S'1471-2431-9-73.PMC2797495.pdf'
p2430
sa(dp2431
g3
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p2432
sg5
S'PMC2688118'
p2433
sg7
VSTD-Taniguchi-2009
p2434
sg9
V19171056.xml
p2435
sg11
S'cc7695.PMC2688118.pdf'
p2436
sa(dp2437
g3
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p2438
sg5
S'PMC1971055'
p2439
sg7
VSTD-Houghton-2007
p2440
sg9
V17629923.xml
p2441
sg11
S'1465-9921-8-52.PMC1971055.pdf'
p2442
sa(dp2443
g3
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p2444
sg5
S'PMC2247136'
p2445
sg7
VSTD-Spiro-1989
p2446
sg9
V2540788.xml
p2447
sg11
S'brjcancer00126-0096.PMC2247136.pdf'
p2448
sa(dp2449
g3
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p2450
sg5
S'PMC1915648'
p2451
sg7
VSTD-Wintzen-2007
p2452
sg9
V17285226.xml
p2453
sg11
S'415_2006_Article_186.PMC1915648.pdf'
p2454
sa(dp2455
g3
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p2456
sg5
S'PMC2517154'
p2457
sg7
VSTD-Koninckx-2008
p2458
sg9
V18556683.xml
p2459
sg11
S'den177.PMC2517154.pdf'
p2460
sa(dp2461
g3
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p2462
sg5
S'PMC2194921'
p2463
sg7
VSTD-De-Jong-2008
p2464
sg9
V18213383.xml
p2465
sg11
S'pone.0001475.PMC2194921.pdf'
p2466
sa(dp2467
g3
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p2468
sg5
S'PMC1819386'
p2469
sg7
VSTD-Amirabdollahian-2007
p2470
sg9
V17309791.xml
p2471
sg11
S'1743-0003-4-4.PMC1819386.pdf'
p2472
sa(dp2473
g3
g2468
sg5
S'PMC1550245'
p2474
sg7
VSTD-Kahn-2006
p2475
sg9
V16790067.xml
p2476
sg11
S'1743-0003-3-12.PMC1550245.pdf'
p2477
sa(dp2478
g3
VCD007139 v. 3.0 Alprazolam for depression.rm5
p2479
sg5
S'PMC2988295'
p2480
sg7
VSTD-Murthy-1991
p2481
sg9
V21897464.xml
p2482
sg11
S'IJPsy-33-104.PMC2988295.pdf'
p2483
sa(dp2484
g3
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p2485
sg5
S'PMC2945135'
p2486
sg7
VSTD-Jhanji-2010
p2487
sg9
V20698956.xml
p2488
sg11
S'cc9220.PMC2945135.pdf'
p2489
sa(dp2490
g3
g2485
sg5
S'PMC3218998'
p2491
sg7
VSTD-Cecconi-2011
p2492
sg9
V21624138.xml
p2493
sg11
S'cc10246.PMC3218998.pdf'
p2494
sa(dp2495
g3
g2485
sg5
S'PMC1414018'
p2496
sg7
VSTD-Pearse-2005
p2497
sg9
V16356219.xml
p2498
sg11
S'cc3887.PMC1414018.pdf'
p2499
sa(dp2500
g3
g2485
sg5
S'PMC2875533'
p2501
sg7
VSTD-Mayer-2010
p2502
sg9
V20156348.xml
p2503
sg11
S'cc8875.PMC2875533.pdf'
p2504
sa(dp2505
g3
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p2506
sg5
S'PMC2063039'
p2507
sg7
VSTD-Cote-1998
p2508
sg9
V9703292.xml
p2509
sg11
S'brjcancer00003-0137.PMC2063039.pdf'
p2510
sa(dp2511
g3
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p2512
sg5
S'PMC1829425'
p2513
sg7
VSTD-Unrod-2007
p2514
sg9
V17372796.xml
p2515
sg11
S'11606_2006_Article_69.PMC1829425.pdf'
p2516
sa(dp2517
g3
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p2518
sg5
S'PMC126226'
p2519
sg7
VSTD-Clifford-2002
p2520
sg9
V12213183.xml
p2521
sg11
S'1472-6963-2-18.PMC126226.pdf'
p2522
sa(dp2523
g3
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p2524
sg5
S'PMC2796994'
p2525
sg7
VSTD-Leehey-2009
p2526
sg9
V20003224.xml
p2527
sg11
S'1475-2840-8-62.PMC2796994.pdf'
p2528
sa(dp2529
g3
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p2530
sg5
S'PMC1201146'
p2531
sg7
VSTD-Baer-2005
p2532
sg9
V16086839.xml
p2533
sg11
S'1471-2474-6-44.PMC1201146.pdf'
p2534
sa(dp2535
g3
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p2536
sg5
S'PMC2595562'
p2537
sg7
VSTD-Cowett-1977
p2538
sg9
V602256.xml
p2539
sg11
S'yjbm00140-0025.PMC2595562.pdf'
p2540
sa(dp2541
g3
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p2542
sg5
S'PMC2582655'
p2543
sg7
VSTD-Halpern-2008
p2544
sg9
V19023429.xml
p2545
sg11
S'pone.0003784.PMC2582655.pdf'
p2546
sa(dp2547
g3
g2542
sg5
S'PMC2129116'
p2548
sg7
VSTD-Peterson-2007
p2549
sg9
V18091987.xml
p2550
sg11
S'pone.0001312.PMC2129116.pdf'
p2551
sa(dp2552
g3
g2542
sg5
S'PMC2190795'
p2553
sg7
VSTD-Feldblum-2008
p2554
sg9
V18213382.xml
p2555
sg11
S'pone.0001474.PMC2190795.pdf'
p2556
sa(dp2557
g3
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p2558
sg5
S'PMC2409543'
p2559
sg7
VSTD-Ahmedzai-2004
p2560
sg9
V14735178.xml
p2561
sg11
S'90-6601527a.PMC2409543.pdf'
p2562
sa(dp2563
g3
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p2564
sg5
S'PMC2265270'
p2565
sg7
VSTD-Innes-2007
p2566
sg9
V18096042.xml
p2567
sg11
S'1472-6831-7-18.PMC2265270.pdf'
p2568
sa(dp2569
g3
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p2570
sg5
S'PMC2858204'
p2571
sg7
VSTD-Londahl-2010
p2572
sg9
V20427683.xml
p2573
sg11
S'zdc998.PMC2858204.pdf'
p2574
sa(dp2575
g3
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p2576
sg5
S'PMC2360651'
p2577
sg7
VSTD-GICOG
p2578
sg9
V16868539.xml
p2579
sg11
S'95-6603279a.PMC2360651.pdf'
p2580
sa(dp2581
g3
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p2582
sg5
S'PMC3476076'
p2583
sg7
VSTD-Oosterhof-2006
p2584
sg9
V16897618.xml
p2585
sg11
S'10194_2006_Article_309.PMC3476076.pdf'
p2586
sa(dp2587
g3
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p2588
sg5
S'PMC2778673'
p2589
sg7
VSTD-Van-Koningsveld-2004
p2590
sg9
V17426908.xml
p2591
sg11
S'415_2006_Article_515.PMC2778673.pdf'
p2592
sa(dp2593
g3
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p2594
sg5
S'PMC2720945'
p2595
sg7
VSTD-Worth-2009
p2596
sg9
V19624838.xml
p2597
sg11
S'1465-9921-10-69.PMC2720945.pdf'
p2598
sa(dp2599
g3
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p2600
sg5
S'PMC2074576'
p2601
sg7
VSTD-Moroni-1996
p2602
sg9
V8688342.xml
p2603
sg11
S'brjcancer00018-0149.PMC2074576.pdf'
p2604
sa(dp2605
g3
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p2606
sg5
S'PMC2483870'
p2607
sg7
VSTD-Webster-2008
p2608
sg9
V18614482.xml
p2609
sg11
S'bmj-337-7662-res-00157-el.PMC2483870.pdf'
p2610
sa(dp2611
g3
g2606
sg5
S'PMC2944158'
p2612
sg7
VSTD-Rickard-2010
p2613
sg9
V20831782.xml
p2614
sg11
S'1741-7015-8-53.PMC2944158.pdf'
p2615
sa(dp2616
g3
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p2617
sg5
S'PMC1802727'
p2618
sg7
VSTD-Henker-2007a
p2619
sg9
V17287932.xml
p2620
sg11
S'431_2007_Article_419.PMC1802727.pdf'
p2621
sa(dp2622
g3
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p2623
sg5
S'PMC2395320'
p2624
sg7
VSTD-Delvaux-2004
p2625
sg9
V14710215.xml
p2626
sg11
S'90-6601459a.PMC2395320.pdf'
p2627
sa(dp2628
g3
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p2629
sg5
S'PMC3302709'
p2630
sg7
VSTD-Tehraninejad-2010
p2631
sg9
V22427771.xml
p2632
sg11
S'AMS-6-6-945.PMC3302709.pdf'
p2633
sa(dp2634
g3
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p2635
sg5
S'PMC2532957'
p2636
sg7
VSTD-Turpeinen-2008
p2637
sg9
V17634183.xml
p2638
sg11
S'ADC-93-08-0654.PMC2532957.pdf'
p2639
sa(dp2640
g3
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p2641
sg5
S'PMC2386789'
p2642
sg7
VSTD-Lenssen-2008
p2643
sg9
V18442423.xml
p2644
sg11
S'1471-2474-9-60.PMC2386789.pdf'
p2645
sa(dp2646
g3
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p2647
sg5
S'PMC2621339'
p2648
sg7
VSTD-Fern_x00e1_ndez-2009
p2649
sg9
V19165321.xml
p2650
sg11
S'pone.0004244.PMC2621339.pdf'
p2651
sa(dp2652
g3
g2647
sg5
S'PMC2034550'
p2653
sg7
VSTD-Gal_x00e1_n-2007
p2654
sg9
V17760974.xml
p2655
sg11
S'1471-2458-7-224.PMC2034550.pdf'
p2656
sa(dp2657
g3
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p2658
sg5
S'PMC2629970'
p2659
sg7
VSTD-Tonnel-2008
p2660
sg9
V18686739.xml
p2661
sg11
S'COPD-3-301.PMC2629970.pdf'
p2662
sa(dp2663
g3
g2658
sg5
S'PMC2921687'
p2664
sg7
VSTD-Bateman-2010b
p2665
sg9
V20714373.xml
p2666
sg11
S'copd-5-197.PMC2921687.pdf'
p2667
sa(dp2668
g3
g2658
sg5
S'PMC1913915'
p2669
sg7
VSTD-Freeman-2007
p2670
sg9
V17605774.xml
p2671
sg11
S'1465-9921-8-45.PMC1913915.pdf'
p2672
sa(dp2673
g3
g2658
sg5
S'PMC3078679'
p2674
sg7
VSTD-Trooster-2011
p2675
sg9
V21503263.xml
p2676
sg11
S'TORMJ-5-1.PMC3078679.pdf'
p2677
sa(dp2678
g3
g2658
sg5
S'PMC2981152'
p2679
sg7
VSTD-Cooper-2010
p2680
sg9
V21103404.xml
p2681
sg11
S'copd-5-375.PMC2981152.pdf'
p2682
sa(dp2683
g3
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p2684
sg5
S'PMC2671765'
p2685
sg7
VSTD-Choung-2008
p2686
sg9
V19434268.xml
p2687
sg11
S'ceo-1-201.PMC2671765.pdf'
p2688
sa(dp2689
g3
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p2690
sg5
S'PMC2394317'
p2691
sg7
VSTD-Bertuzzi-2003
p2692
sg9
V14520438.xml
p2693
sg11
S'89-6601304a.PMC2394317.pdf'
p2694
sa(dp2695
g3
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p2696
sg5
S'PMC1804104'
p2697
sg7
VSTD-Leung-2006
p2698
sg9
V17176279.xml
p2699
sg11
S'bjo0113-1459.PMC1804104.pdf'
p2700
sa(dp2701
g3
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p2702
sg5
S'PMC2873340'
p2703
sg7
VSTD-Scabini-2010
p2704
sg9
V20433721.xml
p2705
sg11
S'1477-7819-8-35.PMC2873340.pdf'
p2706
sa(dp2707
g3
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p2708
sg5
S'PMC3001155'
p2709
sg7
VSTD-Syed-2006
p2710
sg9
V17591348.xml
p2711
sg11
S'jhpn0024-0508.PMC3001155.pdf'
p2712
sa(dp2713
g3
g2708
sg5
S'PMC3001156'
p2714
sg7
VSTD-Bari-2006
p2715
sg9
V17591349.xml
p2716
sg11
S'jhpn0024-0519.PMC3001156.pdf'
p2717
sa(dp2718
g3
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p2719
sg5
S'PMC2666740'
p2720
sg7
VSTD-Tweyongyere-2009-UGA
p2721
sg9
V19296834.xml
p2722
sg11
S'1471-2334-9-32.PMC2666740.pdf'
p2723
sa(dp2724
g3
g2719
sg5
S'PMC3114749'
p2725
sg7
VSTD-Olliaro-2011-TZA
p2726
sg9
V21695161.xml
p2727
sg11
S'pntd.0001165.PMC3114749.pdf'
p2728
sa(dp2729
g3
g2719
sg5
S'PMC3114749'
p2730
sg7
VSTD-Olliaro-2011-MRT
p2731
sg9
V21695161.xml
p2732
sg11
S'pntd.0001165.PMC3114749.pdf'
p2733
sa(dp2734
g3
g2719
sg5
S'PMC3114749'
p2735
sg7
VSTD-Olliaro-2011-BRA
p2736
sg9
V21695161.xml
p2737
sg11
S'pntd.0001165.PMC3114749.pdf'
p2738
sa(dp2739
g3
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p2740
sg5
S'PMC2759981'
p2741
sg7
VSTD-Bergstrom-2009
p2742
sg9
V19538406.xml
p2743
sg11
S'bjo0116-1167.PMC2759981.pdf'
p2744
sa(dp2745
g3
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p2746
sg5
S'PMC2365600'
p2747
sg7
VSTD-Fiocchi-1994
p2748
sg9
V18475604.xml
p2749
sg11
S'MI-03-S43.PMC2365600.pdf'
p2750
sa(dp2751
g3
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p2752
sg5
S'PMC2287184'
p2753
sg7
VSTD-Kouyate-2008
p2754
sg9
V18364043.xml
p2755
sg11
S'1475-2875-7-50.PMC2287184.pdf'
p2756
sa(dp2757
g3
g2752
sg5
S'PMC2636685'
p2758
sg7
VSTD-MacArthur-2009
p2759
sg9
V19181730.xml
p2760
sg11
S'bmj.b131.PMC2636685.pdf'
p2761
sa(dp2762
g3
g2752
sg5
S'PMC3001156'
p2763
sg7
VSTD-Bari-2006
p2764
sg9
V17591349.xml
p2765
sg11
S'jhpn0024-0519.PMC3001156.pdf'
p2766
sa(dp2767
g3
g2752
sg5
S'PMC2628301'
p2768
sg7
VSTD-Dennis-2009
p2769
sg9
V19147637.xml
p2770
sg11
S'bmj.a3064.PMC2628301.pdf'
p2771
sa(dp2772
g3
g2752
sg5
S'PMC2740673'
p2773
sg7
VSTD-Zaman-2008
p2774
sg9
V18686554.xml
p2775
sg11
S'jhpn0026-0210.PMC2740673.pdf'
p2776
sa(dp2777
g3
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p2778
sg5
S'PMC153443'
p2779
sg7
VSTD-Karatzas-2002
p2780
sg9
V12512504.xml
p2781
sg11
S'cc1837.PMC153443.pdf'
p2782
sa(dp2783
g3
g2778
sg5
S'PMC125317'
p2784
sg7
VSTD-Tugrul-2002
p2785
sg9
V12225613.xml
p2786
sg11
S'cc1523.PMC125317.pdf'
p2787
sa(dp2788
g3
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p2789
sg5
S'PMC2681204'
p2790
sg7
VSTD-Johnson-2009
p2791
sg9
V19440519.xml
p2792
sg11
S'ijerph-06-01298.PMC2681204.pdf'
p2793
sa(dp2794
g3
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p2795
sg5
S'PMC2364515'
p2796
sg7
VSTD-Edwards-1996
p2797
sg9
V18476121.xml
p2798
sg11
S'IDOG-04-333.PMC2364515.pdf'
p2799
sa(dp2800
g3
g2795
sg5
S'PMC2364533'
p2801
sg7
VSTD-Martin-1997
p2802
sg9
V18476128.xml
p2803
sg11
S'IDOG-05-010.PMC2364533.pdf'
p2804
sa(dp2805
g3
g2795
sg5
S'PMC2364446'
p2806
sg7
VSTD-Rosenn-1995
p2807
sg9
V18476049.xml
p2808
sg11
S'IDOG-03-241.PMC2364446.pdf'
p2809
sa(dp2810
g3
g2795
sg5
S'PMC2364394'
p2811
sg7
VSTD-Turrentine-1995
p2812
sg9
V18475393.xml
p2813
sg11
S'IDOG-02-205.PMC2364394.pdf'
p2814
sa(dp2815
g3
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p2816
sg5
S'PMC1156915'
p2817
sg7
VSTD-Khanna-2005
p2818
sg9
V15946379.xml
p2819
sg11
S'1471-2482-5-11.PMC1156915.pdf'
p2820
sa(dp2821
g3
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p2822
sg5
S'PMC2864284'
p2823
sg7
VSTD-Awab-2010-AFG
p2824
sg9
V20409302.xml
p2825
sg11
S'1475-2875-9-105.PMC2864284.pdf'
p2826
sa(dp2827
g3
g2822
sg5
S'PMC1261533'
p2828
sg7
VSTD-Hutagalung-2005-THA
p2829
sg9
V16179089.xml
p2830
sg11
S'1475-2875-4-46.PMC1261533.pdf'
p2831
sa(dp2832
g3
g2822
sg5
S'PMC3022577'
p2833
sg7
VSTD-Poravuth-2010-ASIA
p2834
sg9
V21267072.xml
p2835
sg11
S'pone.0014501.PMC3022577.pdf'
p2836
sa(dp2837
g3
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p2838
sg5
S'PMC2792228'
p2839
sg7
VSTD-Kralikova-2009
p2840
sg9
V19943947.xml
p2841
sg11
S'1471-2458-9-433.PMC2792228.pdf'
p2842
sa(dp2843
g3
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p2844
sg5
S'PMC1187893'
p2845
sg7
VSTD-Thorstensson-2005
p2846
sg9
V15924620.xml
p2847
sg11
S'1471-2474-6-27.PMC1187893.pdf'
p2848
sa(dp2849
g3
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p2850
sg5
S'PMC3015649'
p2851
sg7
VSTD-Zorlu-2005
p2852
sg9
V16381364.xml
p2853
sg11
S'jsls-9-4-442.PMC3015649.pdf'
p2854
sa(dp2855
g3
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p2856
sg5
S'PMC3476139'
p2857
sg7
VSTD-Misra-2007
p2858
sg9
V17563841.xml
p2859
sg11
S'10194_2007_Article_386.PMC3476139.pdf'
p2860
sa(dp2861
g3
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p2862
sg5
S'PMC2671976'
p2863
sg7
VSTD-Chan-2008
p2864
sg9
V19142552.xml
p2865
sg11
S'cln64_1p0051.PMC2671976.pdf'
p2866
sa(dp2867
g3
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p2868
sg5
S'PMC2597744'
p2869
sg7
VSTD-Li-2008
p2870
sg9
V19081791.xml
p2871
sg11
S'pone.0003918.PMC2597744.pdf'
p2872
sa(dp2873
g3
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p2874
sg5
S'PMC2361245'
p2875
sg7
VSTD-Wattchow-2006
p2876
sg9
V16622437.xml
p2877
sg11
S'94-6603052a.PMC2361245.pdf'
p2878
sa(dp2879
g3
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p2880
sg5
S'PMC2744824'
p2881
sg7
VSTD-Russell_x002d_Jones-2009
p2882
sg9
V19688338.xml
p2883
sg11
S'125_2009_Article_1472.PMC2744824.pdf'
p2884
sa(dp2885
g3
g2880
sg5
S'PMC1974817'
p2886
sg7
VSTD-Home-2007
p2887
sg9
V17403121.xml
p2888
sg11
S'dme0024-0618.PMC1974817.pdf'
p2889
sa(dp2890
g3
g2880
sg5
S'PMC2699702'
p2891
sg7
VSTD-Zinman-2009
p2892
sg9
V19289857.xml
p2893
sg11
S'zdc1224.PMC2699702.pdf'
p2894
sa(dp2895
g3
g2880
sg5
S'PMC2660449'
p2896
sg7
VSTD-List-2009
p2897
sg9
V19114612.xml
p2898
sg11
S'zdc650.PMC2660449.pdf'
p2899
sa(dp2900
g3
g2880
sg5
S'PMC2699710'
p2901
sg7
VSTD-Nauck-2009b
p2902
sg9
V19366970.xml
p2903
sg11
S'zdc1237.PMC2699710.pdf'
p2904
sa(dp2905
g3
g2880
sg5
S'PMC2606836'
p2906
sg7
VSTD-Nauck-2009a
p2907
sg9
V18931095.xml
p2908
sg11
S'84.PMC2606836.pdf'
p2909
sa(dp2910
g3
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p2911
sg5
S'PMC3058082'
p2912
sg7
VSTD-Melfsen-2011
p2913
sg9
V21356037.xml
p2914
sg11
S'1753-2000-5-5.PMC3058082.pdf'
p2915
sa(dp2916
g3
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p2917
sg5
S'PMC3432241'
p2918
sg7
VSTD-T_x00f8_nnesen-2012
p2919
sg9
V22323576.xml
p2920
sg11
S'erj-40-03-548.PMC3432241.pdf'
p2921
sa(dp2922
g3
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p2923
sg5
S'PMC2235909'
p2924
sg7
VSTD-Rosenstock-2008
p2925
sg9
V18204830.xml
p2926
sg11
S'125_2007_Article_911.PMC2235909.pdf'
p2927
sa(dp2928
g3
g2923
sg5
S'PMC2875419'
p2929
sg7
VSTD-Swinnen-2010a
p2930
sg9
V20200301.xml
p2931
sg11
S'zdc1176.PMC2875419.pdf'
p2932
sa(dp2933
g3
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p2934
sg5
S'PMC2579424'
p2935
sg7
VSTD-Westerbeek-2010
p2936
sg9
V18947426.xml
p2937
sg11
S'1471-2431-8-46.PMC2579424.pdf'
p2938
sa(dp2939
g3
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p2940
sg5
S'PMC522835'
p2941
sg7
VSTD-Emet-2004
p2942
sg9
V15312215.xml
p2943
sg11
S'cc2866.PMC522835.pdf'
p2944
sa(dp2945
g3
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p2946
sg5
S'PMC2758937'
p2947
sg7
VSTD-Kuijper-2009
p2948
sg9
V19812130.xml
p2949
sg11
S'bmj.b3883.PMC2758937.pdf'
p2950
sa(dp2951
g3
g2946
sg5
S'PMC3045999'
p2952
sg7
VSTD-Martel-2011
p2953
sg9
V21303529.xml
p2954
sg11
S'1471-2474-12-41.PMC3045999.pdf'
p2955
sa(dp2956
g3
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p2957
sg5
S'PMC2644666'
p2958
sg7
VSTD-Str_x00f6_hlein-2009
p2959
sg9
V19216794.xml
p2960
sg11
S'1756-9966-28-18.PMC2644666.pdf'
p2961
sa(dp2962
g3
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p2963
sg5
S'PMC2361263'
p2964
sg7
VSTD-Manegold-2003
p2965
sg9
V16641904.xml
p2966
sg11
S'94-6603115a.PMC2361263.pdf'
p2967
sa(dp2968
g3
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p2969
sg5
S'PMC2779375'
p2970
sg7
VSTD-van-der-Kooi-2007
p2971
sg9
V17361345.xml
p2972
sg11
S'415_2006_Article_432.PMC2779375.pdf'
p2973
sa(dp2974
g3
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p2975
sg5
S'PMC1831737'
p2976
sg7
VSTD-Gregson-2007
p2977
sg9
V17388666.xml
p2978
sg11
S'pmed.0040102.PMC1831737.pdf'
p2979
sa(dp2980
g3
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p2981
sg5
S'PMC2782968'
p2982
sg7
VSTD-Echeverry-2009
p2983
sg9
V19729522.xml
p2984
sg11
S'zdc2156.PMC2782968.pdf'
p2985
sa(dp2986
g3
g2981
sg5
S'PMC1914073'
p2987
sg7
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p2988
sg9
V17570858.xml
p2989
sg11
S'1471-2296-8-34.PMC1914073.pdf'
p2990
sa(dp2991
g3
g2981
sg5
S'PMC165418'
p2992
sg7
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p2993
sg9
V12747810.xml
p2994
sg11
S'1471-2296-4-7.PMC165418.pdf'
p2995
sa(dp2996
g3
g2981
sg5
S'PMC3024341'
p2997
sg7
VSTD-van-Bastelaar-2011
p2998
sg9
V21216855.xml
p2999
sg11
S'320.PMC3024341.pdf'
p3000
sa(dp3001
g3
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p3002
sg5
S'PMC2448633'
p3003
sg7
VSTD-Campbell-1991
p3004
sg9
V1853495.xml
p3005
sg11
S'ulstermedj00076-0044.PMC2448633.pdf'
p3006
sa(dp3007
g3
g3002
sg5
S'PMC3015295'
p3008
sg7
VSTD-Dabbous-1998
p3009
sg9
V9876753.xml
p3010
sg11
S'jsls-2-3-273.PMC3015295.pdf'
p3011
sa(dp3012
g3
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p3013
sg5
S'PMC524504'
p3014
sg7
VSTD-_x0030_13-Papanikolaou-2004
p3015
sg9
V15450119.xml
p3016
sg11
S'1477-7827-2-70.PMC524504.pdf'
p3017
sa(dp3018
g3
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p3019
sg5
S'PMC1613238'
p3020
sg7
VSTD-RIOTT-2010
p3021
sg9
V17002810.xml
p3022
sg11
S'1477-7517-3-28.PMC1613238.pdf'
p3023
sa(dp3024
g3
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p3025
sg5
S'PMC2449154'
p3026
sg7
VSTD-McElhinney-2000
p3027
sg9
V10881642.xml
p3028
sg11
S'ulstermedj00055-0030.PMC2449154.pdf'
p3029
sa(dp3030
g3
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p3031
sg5
S'PMC2732152'
p3032
sg7
VSTD-Strychar-2009
p3033
sg9
V19542011.xml
p3034
sg11
S'zdc1597.PMC2732152.pdf'
p3035
sa(dp3036
g3
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p3037
sg5
S'PMC212708'
p3038
sg7
VSTD-Barrowman-2003
p3039
sg9
V12877755.xml
p3040
sg11
S'1471-2288-3-13.PMC212708.pdf'
p3041
sa(dp3042
g3
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p3043
sg5
S'PMC2634726'
p3044
sg7
VSTD-Neuhaus-2009
p3045
sg9
V19127261.xml
p3046
sg11
S'6604835a.PMC2634726.pdf'
p3047
sa(dp3048
g3
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p3049
sg5
S'PMC2228066'
p3050
sg7
VSTD-Kylmala-1997
p3051
sg9
V9328156.xml
p3052
sg11
S'brjcancer00171-0117.PMC2228066.pdf'
p3053
sa(dp3054
g3
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p3055
sg5
S'PMC2229665'
p3056
sg7
VSTD-Opiyo-2008
p3057
sg9
V18270586.xml
p3058
sg11
S'pone.0001599.PMC2229665.pdf'
p3059
sa(dp3060
g3
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p3061
sg5
S'PMC2363948'
p3062
sg7
VSTD-Sculier-2001
p3063
sg9
V11720426.xml
p3064
sg11
S'85-6692114a.PMC2363948.pdf'
p3065
sa(dp3066
g3
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p3067
sg5
S'PMC1913555'
p3068
sg7
VSTD-Vedder-2007
p3069
sg9
V17622343.xml
p3070
sg11
S'pone.0000598.PMC1913555.pdf'
p3071
sa(dp3072
g3
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p3073
sg5
S'PMC2708184'
p3074
sg7
VSTD-Westlake-2009
p3075
sg9
V19523207.xml
p3076
sg11
S'1743-0003-6-18.PMC2708184.pdf'
p3077
sa(dp3078
g3
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p3079
sg5
S'PMC3032994'
p3080
sg7
VSTD-Gill-2011
p3081
sg9
V21292711.xml
p3082
sg11
S'bmj.d346.PMC3032994.pdf'
p3083
sa(dp3084
g3
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p3085
sg5
S'PMC1626393'
p3086
sg7
VSTD-Kercsmar-2006
p3087
sg9
V17035145.xml
p3088
sg11
S'ehp0114-001574.PMC1626393.pdf'
p3089
sa(dp3090
g3
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p3091
sg5
S'PMC2865634'
p3092
sg7
VSTD-Cremin-2010
p3093
sg9
V19623481.xml
p3094
sg11
S'10461_2009_Article_9592.PMC2865634.pdf'
p3095
sa(dp3096
g3
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p3097
sg5
S'PMC2924376'
p3098
sg7
VSTD-Swoboda-2010
p3099
sg9
V20808854.xml
p3100
sg11
S'pone.0012140.PMC2924376.pdf'
p3101
sa(dp3102
g3
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p3103
sg5
S'PMC2564802'
p3104
sg7
VSTD-Schiff-2008
p3105
sg9
V18055472.xml
p3106
sg11
S'ARD-67-08-1096.PMC2564802.pdf'
p3107
sa(dp3108
g3
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p3109
sg5
S'PMC2689524'
p3110
sg7
VSTD-Combe-2006
p3111
sg9
V18794178.xml
p3112
sg11
S'ard-68-07-1146.PMC2689524.pdf'
p3113
sa(dp3114
g3
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p3115
sg5
S'PMC3097892'
p3116
sg7
VSTD-Ietswaart-2011
p3117
sg9
V21515905.xml
p3118
sg11
S'awr077.PMC3097892.pdf'
p3119
sa(dp3120
g3
g3115
sg5
S'PMC3309215'
p3121
sg7
VSTD-Yun-2010
p3122
sg9
V22506139.xml
p3123
sg11
S'arm-35-316.PMC3309215.pdf'
p3124
sa(dp3125
g3
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p3126
sg5
S'PMC2673355'
p3127
sg7
VSTD-Hurley-2007
p3128
sg9
V17907147.xml
p3129
sg11
S'art0057-1211.PMC2673355.pdf'
p3130
sa(dp3131
g3
g3126
sg5
S'PMC1525193'
p3132
sg7
VSTD-Nour-2006
p3133
sg9
V16734904.xml
p3134
sg11
S'1479-5868-3-12.PMC1525193.pdf'
p3135
sa(dp3136
g3
g3126
sg5
S'PMC509247'
p3137
sg7
VSTD-Ersek-2004
p3138
sg9
V15285783.xml
p3139
sg11
S'1471-2318-4-7.PMC509247.pdf'
p3140
sa(dp3141
g3
g3126
sg5
S'PMC1382224'
p3142
sg7
VSTD-Smeets-2006
p3143
sg9
V16426449.xml
p3144
sg11
S'1471-2474-7-5.PMC1382224.pdf'
p3145
sa(dp3146
g3
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p3147
sg5
S'PMC153535'
p3148
sg7
VSTD-Forsetlund-2003
p3149
sg9
V12694632.xml
p3150
sg11
S'1472-6920-3-2.PMC153535.pdf'
p3151
sa(dp3152
g3
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p3153
sg5
S'PMC2840539'
p3154
sg7
VSTD-Chappell-2008
p3155
sg9
V20428412.xml
p3156
sg11
S'ijgm-1-91.PMC2840539.pdf'
p3157
sa(dp3158
g3
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p3159
sg5
S'PMC3269419'
p3160
sg7
VSTD-Kolaczinski-2012
p3161
sg9
V22303437.xml
p3162
sg11
S'pone.0028957.PMC3269419.pdf'
p3163
sa(dp3164
g3
g3159
sg5
S'PMC2111052'
p3165
sg7
VSTD-El_x002d_Sayed-2007
p3166
sg9
V18074034.xml
p3167
sg11
S'pone.0001311.PMC2111052.pdf'
p3168
sa(dp3169
g3
g3159
sg5
S'PMC1665467'
p3170
sg7
VSTD-Ledermann-2006
p3171
sg9
V17105658.xml
p3172
sg11
S'1475-2875-5-108.PMC1665467.pdf'
p3173
sa(dp3174
g3
g3159
sg5
S'PMC1995753'
p3175
sg7
VSTD-Shekalaghe-2007
p3176
sg9
V17925871.xml
p3177
sg11
S'pone.0001023.PMC1995753.pdf'
p3178
sa(dp3179
g3
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p3180
sg5
S'PMC2924330'
p3181
sg7
VSTD-Mistiaen-2009
p3182
sg9
V20687915.xml
p3183
sg11
S'1472-6963-10-226.PMC2924330.pdf'
p3184
sa(dp3185
g3
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p3186
sg5
S'PMC3420230'
p3187
sg7
VSTD-PITCH-2012
p3188
sg9
V22695903.xml
p3189
sg11
S'bmj.e3799.PMC3420230.pdf'
p3190
sa(dp3191
g3
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p3192
sg5
S'PMC2656338'
p3193
sg7
VSTD-Mok-2007
p3194
sg9
V19300631.xml
p3195
sg11
S'NDT-3-943.PMC2656338.pdf'
p3196
sa(dp3197
g3
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p3198
sg5
S'PMC3438078'
p3199
sg7
VSTD-Carlini-2012
p3200
sg9
V22768793.xml
p3201
sg11
S'1471-2458-12-507.PMC3438078.pdf'
p3202
sa(dp3203
g3
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p3204
sg5
S'PMC1871574'
p3205
sg7
VSTD-Binnie-2007
p3206
sg9
V17475005.xml
p3207
sg11
S'1472-6831-7-5.PMC1871574.pdf'
p3208
sa(dp3209
g3
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p3210
sg5
S'PMC3233272'
p3211
sg7
VSTD-_x00c5_gren-2011
p3212
sg9
V22066891.xml
p3213
sg11
S'dejc16-444.PMC3233272.pdf'
p3214
sa(dp3215
g3
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p3216
sg5
S'PMC2830179'
p3217
sg7
VSTD-Bennell-2010
p3218
sg9
V20163739.xml
p3219
sg11
S'1471-2474-11-36.PMC2830179.pdf'
p3220
sa(dp3221
g3
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p3222
sg5
S'PMC2944371'
p3223
sg7
VSTD-Jepson-2010
p3224
sg9
V20825660.xml
p3225
sg11
S'1471-2458-10-538.PMC2944371.pdf'
p3226
sa(dp3227
g3
g3222
sg5
S'PMC2921286'
p3228
sg7
VSTD-Bambra-2010
p3229
sg9
V19692738.xml
p3230
sg11
S'jech082743.PMC2921286.pdf'
p3231
sa(dp3232
g3
g3222
sg5
S'PMC2679412'
p3233
sg7
VSTD-Darmstadt-2009
p3234
sg9
V19426469.xml
p3235
sg11
S'1471-2393-9-S1-S6.PMC2679412.pdf'
p3236
sa(dp3237
g3
g3222
sg5
S'PMC2412872'
p3238
sg7
VSTD-Main-2008
p3239
sg9
V18505545.xml
p3240
sg11
S'1471-2458-8-178.PMC2412872.pdf'
p3241
sa(dp3242
g3
g3222
sg5
S'PMC2679409'
p3243
sg7
VSTD-Yakoob-2009
p3244
sg9
V19426466.xml
p3245
sg11
S'1471-2393-9-S1-S3.PMC2679409.pdf'
p3246
sa(dp3247
g3
g3222
sg5
S'PMC2679410'
p3248
sg7
VSTD-Menezes-2009
p3249
sg9
V19426467.xml
p3250
sg11
S'1471-2393-9-S1-S4.PMC2679410.pdf'
p3251
sa(dp3252
g3
g3222
sg5
S'PMC2679411'
p3253
sg7
VSTD-Haws-2009
p3254
sg9
V19426468.xml
p3255
sg11
S'1471-2393-9-S1-S5.PMC2679411.pdf'
p3256
sa(dp3257
g3
g3222
sg5
S'PMC3226237'
p3258
sg7
VSTD-Shea-2009
p3259
sg9
V19828063.xml
p3260
sg11
S'1472-698X-9-S1-S5.PMC3226237.pdf'
p3261
sa(dp3262
g3
g3222
sg5
S'PMC2841444'
p3263
sg7
VSTD-Barros-2010
p3264
sg9
V20233384.xml
p3265
sg11
S'1471-2393-10-S1-S3.PMC2841444.pdf'
p3266
sa(dp3267
g3
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p3268
sg5
S'PMC2572211'
p3269
sg7
VSTD-Collins-2008a
p3270
sg9
V18952682.xml
p3271
sg11
S'bmj.a1735.PMC2572211.pdf'
p3272
sa(dp3273
g3
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p3274
sg5
S'PMC2405936'
p3275
sg7
VSTD-Yeka-2007-UGA
p3276
sg9
V18545692.xml
p3277
sg11
S'pone.0002390.PMC2405936.pdf'
p3278
sa(dp3279
g3
g3274
sg5
S'PMC1697822'
p3280
sg7
VSTD-Van-den-Broek-2004-ZAR
p3281
sg9
V17125496.xml
p3282
sg11
S'1475-2875-5-113.PMC1697822.pdf'
p3283
sa(dp3284
g3
g3274
sg5
S'PMC1181876'
p3285
sg7
VSTD-Yeka-2004-UGA
p3286
sg9
V16033307.xml
p3287
sg11
S'pmed.0020190.PMC1181876.pdf'
p3288
sa(dp3289
g3
g3274
sg5
S'PMC1919387'
p3290
sg7
VSTD-Faye-2003-SEN
p3291
sg9
V17570848.xml
p3292
sg11
S'1475-2875-6-80.PMC1919387.pdf'
p3293
sa(dp3294
g3
g3274
sg5
S'PMC2040506'
p3295
sg7
VSTD-Grande-2005-PER
p3296
sg9
V17971864.xml
p3297
sg11
S'pone.0001101.PMC2040506.pdf'
p3298
sa(dp3299
g3
g3274
sg5
S'PMC1940006'
p3300
sg7
VSTD-Mukhtar-2005-SDN
p3301
sg9
V17631681.xml
p3302
sg11
S'1475-2875-6-92.PMC1940006.pdf'
p3303
sa(dp3304
g3
g3274
sg5
S'PMC2625364'
p3305
sg7
VSTD-Kobbe-2007-GHA
p3306
sg9
V19099594.xml
p3307
sg11
S'1475-2875-7-261.PMC2625364.pdf'
p3308
sa(dp3309
g3
g3274
sg5
S'PMC1876597'
p3310
sg7
VSTD-Kamya-2006-UGA
p3311
sg9
V17525792.xml
p3312
sg11
S'pctr.0020020.PMC1876597.pdf'
p3313
sa(dp3314
g3
g3274
sg5
S'PMC2600646'
p3315
sg7
VSTD-Mens-2007-KEN
p3316
sg9
V19017387.xml
p3317
sg11
S'1475-2875-7-237.PMC2600646.pdf'
p3318
sa(dp3319
g3
g3274
sg5
S'PMC1868032'
p3320
sg7
VSTD-Bonnet-2004-GIN
p3321
sg9
V17477865.xml
p3322
sg11
S'1475-2875-6-54.PMC1868032.pdf'
p3323
sa(dp3324
g3
g3274
sg5
S'PMC1488893'
p3325
sg7
VSTD-Bukirwa-2005-UGA
p3326
sg9
V16871329.xml
p3327
sg11
S'pctr.0010007.PMC1488893.pdf'
p3328
sa(dp3329
g3
g3274
sg5
S'PMC1261533'
p3330
sg7
VSTD-Hutagalung-2002-THA
p3331
sg9
V16179089.xml
p3332
sg11
S'1475-2875-4-46.PMC1261533.pdf'
p3333
sa(dp3334
g3
g3274
sg5
S'PMC1887535'
p3335
sg7
VSTD-Menard-2006-MDG
p3336
sg9
V17519010.xml
p3337
sg11
S'1475-2875-6-65.PMC1887535.pdf'
p3338
sa(dp3339
g3
g3274
sg5
S'PMC2430614'
p3340
sg7
VSTD-Owusu_x002d_Agyei-2006-GHA
p3341
sg9
V18575626.xml
p3342
sg11
S'pone.0002530.PMC2430614.pdf'
p3343
sa(dp3344
g3
g3274
sg5
S'PMC2631542'
p3345
sg7
VSTD-Kayentao-2006-MLI
p3346
sg9
V19128455.xml
p3347
sg11
S'1475-2875-8-5.PMC2631542.pdf'
p3348
sa(dp3349
g3
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p3350
sg5
S'PMC102323'
p3351
sg7
VSTD-Sangdee-2002-_x002a_
p3352
sg9
V11914160.xml
p3353
sg11
S'1472-6882-2-3.PMC102323.pdf'
p3354
sa(dp3355
g3
g3350
sg5
S'PMC102323'
p3356
sg7
VSTD-Sangdee-2002-_x002a__x002a_
p3357
sg9
V11914160.xml
p3358
sg11
S'1472-6882-2-3.PMC102323.pdf'
p3359
sa(dp3360
g3
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p3361
sg5
S'PMC293465'
p3362
sg7
VSTD-Assadi-2003
p3363
sg9
V14624703.xml
p3364
sg11
S'1471-244X-3-16.PMC293465.pdf'
p3365
sa(dp3366
g3
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p3367
sg5
S'PMC2988803'
p3368
sg7
VSTD-Nachum-2010
p3369
sg9
V21054896.xml
p3370
sg11
S'1477-7827-8-136.PMC2988803.pdf'
p3371
sa(dp3372
g3
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p3373
sg5
S'PMC2200659'
p3374
sg7
VSTD-Zwarenstein-2007
p3375
sg9
V17892588.xml
p3376
sg11
S'1748-5908-2-30.PMC2200659.pdf'
p3377
sa(dp3378
g3
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p3379
sg5
S'PMC3013310'
p3380
sg7
VSTD-Quadri-1980
p3381
sg9
V22058460.xml
p3382
sg11
S'IJPsy-22-182.PMC3013310.pdf'
p3383
sa(dp3384
g3
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p3385
sg5
S'PMC2223779'
p3386
sg7
VSTD-Avril-1997
p3387
sg9
V9218740.xml
p3388
sg11
S'brjcancer00165-0104.PMC2223779.pdf'
p3389
sa(dp3390
g3
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p3391
sg5
S'PMC1764008'
p3392
sg7
VSTD-Nafisi-2006
p3393
sg9
V17176461.xml
p3394
sg11
S'1471-2253-6-15.PMC1764008.pdf'
p3395
sa(dp3396
g3
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p3397
sg5
S'PMC2841102'
p3398
sg7
VSTD-Zehnder-2010
p3399
sg9
V20181120.xml
p3400
sg11
S'1753-2000-4-7.PMC2841102.pdf'
p3401
sa(dp3402
g3
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p3403
sg5
S'PMC2928084'
p3404
sg7
VSTD-Ghana-2009
p3405
sg9
V19902797.xml
p3406
sg11
S'jhpn0027-0619.PMC2928084.pdf'
p3407
sa(dp3408
g3
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p3409
sg5
S'PMC2443081'
p3410
sg7
VSTD-Kapoor-1996
p3411
sg9
V8725454.xml
p3412
sg11
S'HPB-09-145.PMC2443081.pdf'
p3413
sa(dp3414
g3
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p3415
sg5
S'PMC3221969'
p3416
sg7
VSTD-Yip-2011
p3417
sg9
V21269484.xml
p3418
sg11
S'cc10002.PMC3221969.pdf'
p3419
sa(dp3420
g3
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p3421
sg5
S'PMC2375187'
p3422
sg7
VSTD-Matsumoto-2002
p3423
sg9
V11870500.xml
p3424
sg11
S'86-6600048a.PMC2375187.pdf'
p3425
sa(dp3426
g3
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p3427
sg5
S'PMC2565581'
p3428
sg7
VSTD-LOTUS-Trial-2008
p3429
sg9
V18469091.xml
p3430
sg11
S'GUT-57-09-1207.PMC2565581.pdf'
p3431
sa(dp3432
g3
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p3433
sg5
S'PMC3187863'
p3434
sg7
VSTD-Bernitz-2011
p3435
sg9
V21749629.xml
p3436
sg11
S'bjo0118-1357.PMC3187863.pdf'
p3437
sa(dp3438
g3
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p3439
sg5
S'PMC1852268'
p3440
sg7
VSTD-Scalambrino-1989
p3441
sg9
V12839630.xml
p3442
sg11
S'IDOG-11-027.PMC1852268.pdf'
p3443
sa(dp3444
g3
g3439
sg5
S'PMC2364549'
p3445
sg7
VSTD-Chatwani-1997
p3446
sg9
V18476152.xml
p3447
sg11
S'IDOG-05-280.PMC2364549.pdf'
p3448
sa(dp3449
g3
g3439
sg5
S'PMC2364413'
p3450
sg7
VSTD-Chatwani-1995
p3451
sg9
V18475417.xml
p3452
sg11
S'IDOG-03-028.PMC2364413.pdf'
p3453
sa(dp3454
g3
g3439
sg5
S'PMC1852268'
p3455
sg7
VSTD-Roy-2003
p3456
sg9
V12839630.xml
p3457
sg11
S'IDOG-11-027.PMC1852268.pdf'
p3458
sa(dp3459
g3
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p3460
sg5
S'PMC2527421'
p3461
sg7
VSTD-van-der-Roer-2008
p3462
sg9
V18663487.xml
p3463
sg11
S'586_2008_Article_718.PMC2527421.pdf'
p3464
sa(dp3465
g3
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p3466
sg5
S'PMC3299559'
p3467
sg7
VSTD-Nakakura-2012
p3468
sg9
V22419858.xml
p3469
sg11
S'opth-6-369.PMC3299559.pdf'
p3470
sa(dp3471
g3
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p3472
sg5
S'PMC2945152'
p3473
sg7
VSTD-Lazo-2010
p3474
sg9
V20664019.xml
p3475
sg11
S'zdc2156.PMC2945152.pdf'
p3476
sa(dp3477
g3
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p3478
sg5
S'PMC2373885'
p3479
sg7
VSTD-Harms-2008
p3480
sg9
V18478129.xml
p3481
sg11
S'pone.0002158.PMC2373885.pdf'
p3482
sa(dp3483
g3
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p3484
sg5
S'PMC2443289'
p3485
sg7
VSTD-Begley-2008
p3486
sg9
V18628946.xml
p3487
sg11
S'pone.0002731.PMC2443289.pdf'
p3488
sa(dp3489
g3
g3484
sg5
S'PMC2888758'
p3490
sg7
VSTD-Lane-2011
p3491
sg9
V19662523.xml
p3492
sg11
S'10461_2009_Article_9598.PMC2888758.pdf'
p3493
sa(dp3494
g3
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p3495
sg5
S'PMC2571107'
p3496
sg7
VSTD-Abeku-2008a
p3497
sg9
V18834523.xml
p3498
sg11
S'1475-2875-7-202.PMC2571107.pdf'
p3499
sa(dp3500
g3
g3495
sg5
S'PMC2571107'
p3501
sg7
VSTD-Abeku-2008b
p3502
sg9
V18834523.xml
p3503
sg11
S'1475-2875-7-202.PMC2571107.pdf'
p3504
sa(dp3505
g3
g3495
sg5
S'PMC2667629'
p3506
sg7
VSTD-Msellem-2009
p3507
sg9
V19399156.xml
p3508
sg11
S'pmed.1000070.PMC2667629.pdf'
p3509
sa(dp3510
g3
g3495
sg5
S'PMC2478667'
p3511
sg7
VSTD-Bharti-2008
p3512
sg9
V18620560.xml
p3513
sg11
S'1475-2875-7-126.PMC2478667.pdf'
p3514
sa(dp3515
g3
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p3516
sg5
S'PMC2565674'
p3517
sg7
VSTD-Arezzo-2008
p3518
sg9
V18796160.xml
p3519
sg11
S'1471-2377-8-33.PMC2565674.pdf'
p3520
sa(dp3521
g3
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p3522
sg5
S'PMC2680337'
p3523
sg7
VSTD-Choo-2008
p3524
sg9
V19143854.xml
p3525
sg11
S'ijcp0062-1675.PMC2680337.pdf'
p3526
sa(dp3527
g3
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p3528
sg5
S'PMC2871176'
p3529
sg7
VSTD-L-_x002d_-LEAD-1-Marre-2009
p3530
sg9
V19317822.xml
p3531
sg11
S'dme0026-0268.PMC2871176.pdf'
p3532
sa(dp3533
g3
g3528
sg5
S'PMC3068287'
p3534
sg7
VSTD-Lixi-_x002d_-Ratner-2010
p3535
sg9
V20722676.xml
p3536
sg11
S'dme0027-1024.PMC3068287.pdf'
p3537
sa(dp3538
g3
g3528
sg5
S'PMC2699710'
p3539
sg7
VSTD-T-_x002d_-Nauck-2009
p3540
sg9
V19366970.xml
p3541
sg11
S'zdc1237.PMC2699710.pdf'
p3542
sa(dp3543
g3
g3528
sg5
S'PMC2752910'
p3544
sg7
VSTD-A-_x002d_-Rosenstock-2009
p3545
sg9
V19592625.xml
p3546
sg11
S'zdc1880.PMC2752910.pdf'
p3547
sa(dp3548
g3
g3528
sg5
S'PMC2606836'
p3549
sg7
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p3550
sg9
V18931095.xml
p3551
sg11
S'84.PMC2606836.pdf'
p3552
sa(dp3553
g3
g3528
sg5
S'PMC2744824'
p3554
sg7
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p3555
sg9
V19688338.xml
p3556
sg11
S'125_2009_Article_1472.PMC2744824.pdf'
p3557
sa(dp3558
g3
g3528
sg5
S'PMC2699702'
p3559
sg7
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p3560
sg9
V19289857.xml
p3561
sg11
S'zdc1224.PMC2699702.pdf'
p3562
sa(dp3563
g3
g3528
sg5
S'PMC2948428'
p3564
sg7
VSTD-T_x002d_-Ratner-2010
p3565
sg9
V20536952.xml
p3566
sg11
S'dme0027-0556.PMC2948428.pdf'
p3567
sa(dp3568
g3
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p3569
sg5
S'PMC3015351'
p3570
sg7
VSTD-Feste-2000
p3571
sg9
V10772522.xml
p3572
sg11
S'jsls-4-1-11.PMC3015351.pdf'
p3573
sa(dp3574
g3
g3569
sg5
S'PMC3015718'
p3575
sg7
VSTD-Venkatesh-2007
p3576
sg9
V17761080.xml
p3577
sg11
S'jsls-11-2-198.PMC3015718.pdf'
p3578
sa(dp3579
g3
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p3580
sg5
S'PMC2364768'
p3581
sg7
VSTD-Wells-2004
p3582
sg9
V15238983.xml
p3583
sg11
S'91-6601998a.PMC2364768.pdf'
p3584
sa(dp3585
g3
g3580
sg5
S'PMC2634705'
p3586
sg7
VSTD-King-2009
p3587
sg9
V19107130.xml
p3588
sg11
S'6604836a.PMC2634705.pdf'
p3589
sa(dp3590
g3
g3580
sg5
S'PMC2361245'
p3591
sg7
VSTD-Wattchow-2006
p3592
sg9
V16622437.xml
p3593
sg11
S'94-6603052a.PMC2361245.pdf'
p3594
sa(dp3595
g3
g3580
sg5
S'PMC2364271'
p3596
sg7
VSTD-Hanks-2002
p3597
sg9
V12232756.xml
p3598
sg11
S'87-6600522a.PMC2364271.pdf'
p3599
sa(dp3600
g3
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p3601
sg5
S'PMC2717450'
p3602
sg7
VSTD-Hochreiter-2009
p3603
sg9
V19493352.xml
p3604
sg11
S'cc7903.PMC2717450.pdf'
p3605
sa(dp3606
g3
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p3607
sg5
S'PMC2375236'
p3608
sg7
VSTD-Brown-2001
p3609
sg9
V11720460.xml
p3610
sg11
S'85-6692073a.PMC2375236.pdf'
p3611
sa(dp3612
g3
g3607
sg5
S'PMC2363012'
p3613
sg7
VSTD-Brown-1999
p3614
sg9
V10390003.xml
p3615
sg11
S'80-6690346a.PMC2363012.pdf'
p3616
sa(dp3617
g3
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p3618
sg5
S'PMC2217593'
p3619
sg7
VSTD-Ramakrishna-2008
p3620
sg9
V18270575.xml
p3621
sg11
S'pone.0001587.PMC2217593.pdf'
p3622
sa(dp3623
g3
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p3624
sg5
S'PMC2945155'
p3625
sg7
VSTD-Juvenile-2009
p3626
sg9
V20696865.xml
p3627
sg11
S'zdc2175.PMC2945155.pdf'
p3628
sa(dp3629
g3
g3624
sg5
S'PMC2782985'
p3630
sg7
VSTD-Raccah-2009
p3631
sg9
V19767384.xml
p3632
sg11
S'zdc2245.PMC2782985.pdf'
p3633
sa(dp3634
g3
g3624
sg5
S'PMC3064030'
p3635
sg7
VSTD-Battelino-2011
p3636
sg9
V21335621.xml
p3637
sg11
S'795.PMC3064030.pdf'
p3638
sa(dp3639
g3
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p3640
sg5
S'PMC1550871'
p3641
sg7
VSTD-Luckner-2006
p3642
sg9
V16542484.xml
p3643
sg11
S'cc4845.PMC1550871.pdf'
p3644
sa(dp3645
g3
g3640
sg5
S'PMC2750187'
p3646
sg7
VSTD-Morelli-2009
p3647
sg9
V19664253.xml
p3648
sg11
S'cc7990.PMC2750187.pdf'
p3649
sa(dp3650
g3
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p3651
sg5
S'PMC1968186'
p3652
sg7
VSTD-Fraser-1993
p3653
sg9
V8431375.xml
p3654
sg11
S'brjcancer00204-0200.PMC1968186.pdf'
p3655
sa(dp3656
g3
g3651
sg5
S'PMC2362871'
p3657
sg7
VSTD-Harper_x002d_Wynne-1999
p3658
sg9
V10496359.xml
p3659
sg11
S'81-6690694a.PMC2362871.pdf'
p3660
sa(dp3661
g3
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p3662
sg5
S'PMC459220'
p3663
sg7
VSTD-Karabay-2004
p3664
sg9
V15214959.xml
p3665
sg11
S'1471-2334-4-18.PMC459220.pdf'
p3666
sa(dp3667
g3
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p3668
sg5
S'PMC1479326'
p3669
sg7
VSTD-Lumley-2006
p3670
sg9
V16483383.xml
p3671
sg11
S'1471-2458-6-37.PMC1479326.pdf'
p3672
sa(dp3673
g3
g3668
sg5
S'PMC2628301'
p3674
sg7
VSTD-Dennis-2009
p3675
sg9
V19147637.xml
p3676
sg11
S'bmj.a3064.PMC2628301.pdf'
p3677
sa(dp3678
g3
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p3679
sg5
S'PMC2292251'
p3680
sg7
VSTD-Gilbert-2008
p3681
sg9
V18431475.xml
p3682
sg11
S'pone.0001988.PMC2292251.pdf'
p3683
sa(dp3684
g3
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p3685
sg5
S'PMC2951534'
p3686
sg7
VSTD-Girish-2003
p3687
sg9
V21206808.xml
p3688
sg11
S'IJPsy-45-21.PMC2951534.pdf'
p3689
sa(dp3690
g3
g3685
sg5
S'PMC3011123'
p3691
sg7
VSTD-Agarwal-1985
p3692
sg9
V21927109.xml
p3693
sg11
S'IJPsy-27-233.PMC3011123.pdf'
p3694
sa(dp3695
g3
g3685
sg5
S'PMC3012902'
p3696
sg7
VSTD-Bagadia-1981
p3697
sg9
V22058556.xml
p3698
sg11
S'IJPsy-23-324.PMC3012902.pdf'
p3699
sa(dp3700
g3
g3685
sg5
S'PMC3012948'
p3701
sg7
VSTD-Janakiramiah-1981
p3702
sg9
V22058544.xml
p3703
sg11
S'IJPsy-23-230.PMC3012948.pdf'
p3704
sa(dp3705
g3
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p3706
sg5
S'PMC1241771'
p3707
sg7
VSTD-Jordan-2003
p3708
sg9
V14644671.xml
p3709
sg11
S'ehp0111-001947.PMC1241771.pdf'
p3710
sa(dp3711
g3
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p3712
sg5
S'PMC2074575'
p3713
sg7
VSTD-Symonds-1996
p3714
sg9
V8688343.xml
p3715
sg11
S'brjcancer00018-0152.PMC2074575.pdf'
p3716
sa(dp3717
g3
g3712
sg5
S'PMC2376383'
p3718
sg7
VSTD-Stokman-2003
p3719
sg9
V12671696.xml
p3720
sg11
S'88-6600824a.PMC2376383.pdf'
p3721
sa(dp3722
g3
g3712
sg5
S'PMC2033386'
p3723
sg7
VSTD-Jebb-1994
p3724
sg9
V7917930.xml
p3725
sg11
S'brjcancer00056-0162.PMC2033386.pdf'
p3726
sa(dp3727
g3
g3712
sg5
S'PMC2246575'
p3728
sg7
VSTD-Mills-1988
p3729
sg9
V3390377.xml
p3730
sg11
S'brjcancer00138-0080.PMC2246575.pdf'
p3731
sa(dp3732
g3
g3712
sg5
S'PMC2363753'
p3733
sg7
VSTD-Hartmann-2001
p3734
sg9
V11161394.xml
p3735
sg11
S'84-6691611a.PMC2363753.pdf'
p3736
sa(dp3737
g3
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p3738
sg5
S'PMC1269449'
p3739
sg7
VSTD-Vargas-2005
p3740
sg9
V16137351.xml
p3741
sg11
S'cc3724.PMC1269449.pdf'
p3742
sa(dp3743
g3
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p3744
sg5
S'PMC3071998'
p3745
sg7
VSTD-N_x00e1_polis-2011
p3746
sg9
V21552662.xml
p3747
sg11
S'cln-66-03-401.PMC3071998.pdf'
p3748
sa(dp3749
g3
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p3750
sg5
S'PMC2760502'
p3751
sg7
VSTD-Nilsson-2009
p3752
sg9
V19781053.xml
p3753
sg11
S'1471-2474-10-118.PMC2760502.pdf'
p3754
sa(dp3755
g3
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p3756
sg5
S'PMC2573879'
p3757
sg7
VSTD-Wahl-2008
p3758
sg9
V18831749.xml
p3759
sg11
S'1472-6882-8-56.PMC2573879.pdf'
p3760
sa(dp3761
g3
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p3762
sg5
S'PMC3233274'
p3763
sg7
VSTD-Mansour-2011
p3764
sg9
V21995590.xml
p3765
sg11
S'dejc16-430.PMC3233274.pdf'
p3766
sa(dp3767
g3
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p3768
sg5
S'PMC2615347'
p3769
sg7
VSTD-Hwang-2008
p3770
sg9
V18581595.xml
p3771
sg11
S'ymj-49-443.PMC2615347.pdf'
p3772
sa(dp3773
g3
g3768
sg5
S'PMC2762035'
p3774
sg7
VSTD-Adamsen-2009
p3775
sg9
V19826172.xml
p3776
sg11
S'bmj.b3410.PMC2762035.pdf'
p3777
sa(dp3778
g3
g3768
sg5
S'PMC2826100'
p3779
sg7
VSTD-Oh-2010
p3780
sg9
V19880433.xml
p3781
sg11
S'mdp479.PMC2826100.pdf'
p3782
sa(dp3783
g3
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p3784
sg5
S'PMC1915628'
p3785
sg7
VSTD-Voerman-2007
p3786
sg9
V17260162.xml
p3787
sg11
S'10926_2007_Article_9066.PMC1915628.pdf'
p3788
sa(dp3789
g3
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p3790
sg5
S'PMC2615347'
p3791
sg7
VSTD-Hwang-2008
p3792
sg9
V18581595.xml
p3793
sg11
S'ymj-49-443.PMC2615347.pdf'
p3794
sa(dp3795
g3
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p3796
sg5
S'PMC547907'
p3797
sg7
VSTD-Carey-2005
p3798
sg9
V15667657.xml
p3799
sg11
S'1471-244X-5-5.PMC547907.pdf'
p3800
sa(dp3801
g3
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p3802
sg5
S'PMC2615347'
p3803
sg7
VSTD-Hwang-2008
p3804
sg9
V18581595.xml
p3805
sg11
S'ymj-49-443.PMC2615347.pdf'
p3806
sa(dp3807
g3
g3802
sg5
S'PMC2762035'
p3808
sg7
VSTD-Adamsen-2009
p3809
sg9
V19826172.xml
p3810
sg11
S'bmj.b3410.PMC2762035.pdf'
p3811
sa(dp3812
g3
g3802
sg5
S'PMC2826100'
p3813
sg7
VSTD-Oh-2010
p3814
sg9
V19880433.xml
p3815
sg11
S'mdp479.PMC2826100.pdf'
p3816
sa(dp3817
g3
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p3818
sg5
S'PMC3015374'
p3819
sg7
VSTD-Lepere-2000
p3820
sg9
V10917122.xml
p3821
sg11
S'jsls-4-2-147.PMC3015374.pdf'
p3822
sa(dp3823
g3
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p3824
sg5
S'PMC1936417'
p3825
sg7
VSTD-Bruggemann-2007
p3826
sg9
V17612408.xml
p3827
sg11
S'1742-4755-4-5.PMC1936417.pdf'
p3828
sa(dp3829
g3
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p3830
sg5
S'PMC2033463'
p3831
sg7
VSTD-Cascinu-1995
p3832
sg9
V7819058.xml
p3833
sg11
S'brjcancer00047-0099.PMC2033463.pdf'
p3834
sa(dp3835
g3
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p3836
sg5
S'PMC2360636'
p3837
sg7
VSTD-Kikuchi-2006
p3838
sg9
V16804523.xml
p3839
sg11
S'95-6603230a.PMC2360636.pdf'
p3840
sa(dp3841
g3
g3836
sg5
S'PMC2364221'
p3842
sg7
VSTD-Hoshiyama-2002
p3843
sg9
V12177800.xml
p3844
sg11
S'87-6600487a.PMC2364221.pdf'
p3845
sa(dp3846
g3
g3836
sg5
S'PMC2409667'
p3847
sg7
VSTD-Suzuki-2004
p3848
sg9
V15054454.xml
p3849
sg11
S'90-6601652a.PMC2409667.pdf'
p3850
sa(dp3851
g3
g3836
sg5
S'PMC2374337'
p3852
sg7
VSTD-Key-1999
p3853
sg9
V10584890.xml
p3854
sg11
S'81-6690837a.PMC2374337.pdf'
p3855
sa(dp3856
g3
g3836
sg5
S'PMC2567088'
p3857
sg7
VSTD-Li-2008
p3858
sg9
V18766189.xml
p3859
sg11
S'6604645a.PMC2567088.pdf'
p3860
sa(dp3861
g3
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p3862
sg5
S'PMC2440307'
p3863
sg7
VSTD-Wright-2008
p3864
sg9
V18261131.xml
p3865
sg11
S'cge0073-0306.PMC2440307.pdf'
p3866
sa(dp3867
g3
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p3868
sg5
S'PMC3232086'
p3869
sg7
VSTD-Baharvand-2010
p3870
sg9
V22615593.xml
p3871
sg11
S'DARU-18-046.PMC3232086.pdf'
p3872
sa(dp3873
g3
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p3874
sg5
S'PMC2922723'
p3875
sg7
VSTD-Osman-2010
p3876
sg9
V19703826.xml
p3877
sg11
S'thorax111492.PMC2922723.pdf'
p3878
sa.